Patent Grant
10500327
The present invention generally relates to hemodialysis and similar dialysis systems, e.g., systems able to treat blood or other bodily fluids extracorporeally.
Many factors make hemodialysis inefficient, difficult, and expensive. These factors include the complexity of hemodialysis, the safety concerns related to hemodialysis, and the very large amount of dialysate needed for hemodialysis. Moreover, hemodialysis is typically performed in a dialysis center requiring skilled technicians. Therefore any increase in the ease and efficiency of the dialysis process could have an impact on treatment cost or patient outcome.
Aspects of the invention generally relate to hemodialysis and similar dialysis systems. Illustrative embodiments described herein involve, in some cases, interrelated products, alternative solutions to a particular problem, and/or a plurality of different uses of one or more systems and/or articles. Although the various systems and methods described herein are described in relation to hemodialysis, it should be understood that the various systems and method described herein are applicable to other dialysis systems and/or in any extracorporeal system able to treat blood or other bodily fluids, such as hemofiltration, hemodiafiltration, etc.
In one aspect of the invention, an enclosure for containing a portable hemodialysis unit is provided, where the hemodialysis unit includes suitable components for performing hemodialysis including a dialyzer, one or more pumps to circulate blood through the dialyzer, a source of dialysate, and one or more pumps to circulate the dialysate through the dialyzer. The enclosure may include a housing that supports the components of the hemodialysis unit and has a front panel at which blood circuit connections and dialysate fluidic connections are located. For example, the front panel may support blood line connections for patient blood access, connections for a reagent supply, dialyzer connections for both blood flow and dialysate, etc. Thus, in one embodiment, an operator may complete all necessary fluid circuit connections for the blood circuit and reagent supply at the housing front panel. The enclosure may also include a pair of vertical, side-by-side doors hingedly mounted to the housing at opposite sides of the front panel so that the doors are movable between open and closed positions. With the doors in an open position, an operator may have access to the blood circuit connections and dialysate fluidic connections. Also, with the doors in the closed position, access to the patient access and dialysate fluidic connections may be blocked, and the doors may allow for the retention of heat in the housing suitable for disinfection during a disinfection cycle. For example, at least one of the doors may include a seal to resist air exchange between an interior and an exterior of housing when the doors are in the closed position to help retain heat and/or help resist entry of dust, dirt or other contaminants.
In one embodiment, each of the vertical, side-by-side doors is mounted to the housing via a hinge plate that is pivotally mounted to the door at a first end, and is pivotally mounted to the housing at a second end opposite the first end. Thus, the doors may be positionable at two open positions, e.g., a first open position in which blood circuit connections and dialysate fluidic connections are exposed and the hinge plate is adjacent the housing, and a second open position in which the hinge plate is positioned away from the housing. One or more retainer members may be included to maintain the doors in an open position relative to a corresponding hinge plate. For example, the retainer member may include at least one magnet attached to the door or the hinge plate that tends to keep the door in an open position relative to the hinge plate and the housing. Also, one or more retainer members may maintain the hinge plates in a closed position relative to the housing, e.g., in a position close to the housing, and/or maintain the hinge plates in an open position away from the housing.
In one embodiment, at least one of the doors may include a container holder that is movable between a folded position and an extended position in which the container holder is arranged to support a container, such as reagent supply container. In addition, or alternately, one or both of the doors may include a hook to support a control interface for the hemodialysis unit, such as a remote interface unit that is connected to the housing by a communication cable. These features may make use of the dialysis unit easier by supporting components in a convenient location.
In another embodiment, the front panel may include at least one flanged portion to support blood lines of a blood circuit assembly. For example, the front panel may include several flanged sections arranged at a periphery of the front panel, such as at lower corners and at a top edge of the front panel. Blood circuit lines that connect to a patient may be relatively long (e.g., up to 3-4 feet or more), and may be wrapped around the periphery of the front panel and retained in place by the flanged portions. The flanged portions may be arranged to support the blood lines and allow the doors to be moved to the closed position without contacting the blood lines, e.g., to avoid pinching of the blood lines at door hinge points.
In one embodiment, the blood circuit connections at the front panel include arterial and venous blood line connectors for the blood circuit, and the dialysate fluidic connections at the front panel include a connection point for a reagent supply, dialyzer dialysate connections, and a blood line connection point for connecting the arterial and venous blood lines to a directing circuit of the dialysis unit.
The hemodialysis unit may include a control interface that is connected to the housing by a flexible cable and that is arranged to allow a user to receive information from and provide information to the hemodialysis unit. In one embodiment, the enclosure may include a control interface mounting area at a top of the enclosure where the control interface is mountable. For example, the control interface may include a foldable leg or other support that permits the control interface to be stood in a near vertical orientation on the top of the housing.
In another embodiment, the enclosure may include an electronics section that is separated and insulated from a disinfection section that is heated to disinfect components of the hemodialysis unit. For example, the disinfection section may include all of the liquid circuit components, such as valves, pumps, conduits, etc., of the various portions of the dialysis unit. The electronics section may include motors, computers or other data processing devices, computer memory, and/or other temperature sensitive electronics or other components. By isolating the electronics section from the disinfection section (at least to some degree), components in the electronics section may be spared exposure to the heat or other environmental conditions in the disinfection section whether during a disinfection operation or otherwise.
In another aspect of the invention, a portable hemodialysis system may be arranged so that power for the fluid circuit pumps of a dialysis unit may be provided by a modular power unit, e.g., a unit that can be selectively connected to or disconnected from the dialysis unit. As a result, failure of a power unit need not necessarily disable the entire dialysis system. Instead, the power unit may be replaced with another power unit, allowing for treatment to continue. For example, a modular assembly for a portable hemodialysis system may include a dialysis unit, e.g., including a housing that contains suitable components for performing hemodialysis, such as a dialyzer, one or more pumps to circulate blood through the dialyzer, a source of dialysate, and one or more pumps to circulate the dialysate through the dialyzer. The housing may have a front panel at which blood circuit connections and dialysate fluidic connections are located, e.g., where an operator may make patient blood access connections, connect a reagent supply, and/or connect a dialyzer. The modular assembly may also include a power unit having a housing that contains suitable components for providing operating power to the pumps of the dialysis unit. The power unit may be selectively connected to the dialysis unit and provide power to the dialysis unit for the pumps when connected to the dialysis unit, but may be incapable of providing power to the dialysis unit when disconnected from the dialysis unit. The power unit may be selectively connected to and disconnected from the dialysis unit by operation of a single handle, e.g., an operator may turn or otherwise operate a single handle to disconnect the power unit from the dialysis unit. In one embodiment, the dialysis unit and the power unit are sized and weighted to each be carried by hand by a human.
In one embodiment, the pumps of the dialysis unit are pneumatic pumps and the power unit provides pneumatic power to the dialysis unit. For example, the power unit may provide air pressure and/or vacuum to the dialysis unit to power the pumps. The power unit may include one or more air pressure pumps and/or air vacuum pumps, and the dialysis unit may include a plurality of valves to control application of pneumatic power to the pumps. To aid with use of the hemodialysis system in the home, the power unit and dialysis unit electrical power requirements may be provided by standard residential electrical power, e.g., approximately 110V, 15 amp electrical power. The dialysis unit may provide electrical power to the power unit, and the power unit may use the electrical power to generate operating power for the pumps.
In another aspect of the invention, a blood circuit assembly for a dialysis unit may be arranged to allow the replacement of most or all blood circuit components in a single operation. For example, the blood circuit assembly may include an organizing tray, a pair of pneumatic pumps mounted to the organizing tray for circulating blood received from a patient through a circuit including a dialyzer unit and returned to the patient, an air trap mounted to the organizing tray arranged to remove air from blood circulating in the circuit, a pair of dialyzer connections arranged to connect to the inlet and outlet of a dialyzer unit, and a pair of blood line connectors, one inlet blood line connector for receiving blood from the patient and providing blood to the pneumatic pumps and the other outlet blood line connector for returning blood to the patient.
In one embodiment, an anticoagulant connection is provided for engaging with an anticoagulant source and providing anticoagulant into the blood circuit. For example, the anticoagulant connection may include a pump for pumping anticoagulant from the anticoagulant source, such as heparin from a vial of heparin, to the circuit. The anticoagulant connection may include a vial holder arranged to hold two or more differently sized vials, and a spike to pierce the vial. In one embodiment, the pair of pneumatic pumps, the anticoagulant connection, and the anticoagulant pump are part of a pump cassette.
In another embodiment, the blood circuit assembly may be selectively mounted to and removed from a dialysis unit. To aid in handling of the blood circuit assembly, the organizing tray may include a pair of handles arranged for gripping by a user. The organizing tray may also include openings adjacent each of the handles for receiving retaining tabs on a dialysis unit that engage with the blood circuit assembly and retain the blood circuit assembly on the dialysis unit.
In one embodiment, the inlet blood line connector is connected to an inlet for the pump cassette, an outlet for the pump cassette is connected to a dialyzer inlet connector, a dialyzer outlet connector is connected to an inlet of the air trap, and an outlet of the air trap is connected to the outlet blood line connector. The inlet of the air trap may be located above the outlet of the air trap when the blood circuit assembly is mounted to a dialysis unit, e.g., to aid in trapping of air circulating in the circuit during treatment. The blood line connectors may be arranged for a threaded luer-type connection to a patient access, as well as be arranged for a press-in type connection to the dialysis unit. Such an arrangement may make it easier for an operator to connect the blood line connectors to the dialysis unit after treatment (e.g., for later disinfection and/or priming of the blood circuit) while allowing the connectors to engage with standard luer-type connectors at a patient blood access.
In one embodiment, the organizing tray may include circuit tube engagement members having a hole or slot through which a respective circuit tube passes. The engagement members may engage with the respective circuit tube to allow the circuit tube to be pulled and stretched for engagement with an occluder of the dialysis unit. For example, the circuit tubes of the blood circuit assembly may include silicone tubing that has to be stretched (and thereby reduced in diameter) to engage with an occluder. The circuit tube engagement members may resist the pull of an operator on the tubes, allowing the tubes to be stretched and placed in engagement with the occluder.
In another aspect of the invention, a method for replacing a blood circuit assembly of a dialysis unit includes grasping a pair of handles on an organizing tray of a blood circuit assembly that is mounted to a dialysis unit, disengaging locking tabs of the dialysis unit from the blood circuit assembly to free the blood circuit assembly from the dialysis unit, and pulling on the handles on the organizing tray of the blood circuit assembly to remove the blood circuit assembly from the dialysis unit. Disengagement of the locking tabs may be performed by flexing the locking tabs away from each other such that each locking tab is moved toward a nearest one of the handles. After removal of the blood circuit assembly, a replacement blood circuit assembly may be provided, openings in the organizing tray of the replacement blood circuit assembly may be aligned with the locking tabs so that each locking tab is received into a respective opening, and the organizing tray may be pushed relative to the dialysis unit such that the locking tabs engage with the replacement blood circuit assembly to mount the replacement blood circuit assembly to the dialysis unit. Mounting the replacement blood circuit assembly may also involve connecting control ports on the dialysis unit to mating ports on the assembly so that fluid control signals may be provided for pumps and valves of the blood circuit assembly. Other blood circuit connections may be made, such as inlet and outlet connections for the dialyzer, and the blood line connectors may be connected to receive dialysate into the blood circuit.
In another aspect of the invention, an air trap for a blood circuit in a dialysis unit includes a blood inlet supply line, a blood outlet supply line, and a container having an approximately spherical internal wall, an inlet at a top end of the container connected to the blood inlet supply line, and an outlet at a bottom end of the container connected to the blood outlet supply line. The inlet may be offset from a vertical axis of the approximately spherical internal wall such that blood entering the container through the inlet is directed to flow in around the approximately spherical wall in a spiral-like path. Such flow in the container may help to remove air bubbles from the blood as it flows from the inlet to the outlet, with any removed air remaining near the top of the container. The inlet port may be arranged to introduce blood into the container in a direction that is approximately tangential to the approximately spherical inner wall of the container and/or in a direction that is approximately perpendicular to the vertical axis of the container.
In one embodiment, a self-sealing port may be located at a top of the container, e.g., in the form of a split septum that is arranged to permit introduction of fluid into, and withdrawal of liquid from, the container by inserting a needleless device through the split septum. The self-sealing port may be arranged to be self-cleaning when disinfection liquid is circulated through the container, e.g., the port may be suitably exposed to flowing disinfection liquid to remove debris and/or heat material on the port to achieve desired disinfection.
In another aspect of the invention, a tube securing arrangement of a blood circuit assembly includes a organizing tray that supports components of a blood circuit assembly and includes a pair of tube engagement members each having a hole, a pair of patient inlet and outlet lines arranged to connect with patient access points for receiving liquid from and/or providing liquid to the patient, and a pair of stops on the patient inlet and outlet lines, respectively. The patient inlet and outlet lines may each pass through a hole of a respective tube engagement member so that the stop engages with the tube engagement member. With this arrangement, the tube engagement members may resist pulling and stretching of the inlet and outlet lines when engaging the lines with an occluder. The tube engagement members may be flexible to allow a user to press inwardly on the engagement member and seat the respective inlet or outlet line in the occluder, yet resist downward pulling of the line.
In another aspect of the invention, a hemodialysis system includes a dialyzer mount arranged to support a plurality of differently sized and/or shaped dialyzer units and to accommodate different distances between dialysate connections on the dialyzer units. The dialyzer mount, which may be located on a front panel of the dialysis unit, may include a pair of flange portions that are each arranged to engage with a respective dialysate quick-connect fitting connected to a dialysate port of the dialyzer. Each flange portion may be arranged to engage with a groove on the quick connect fitting that is located between a portion of the base of the quick connect fitting and a slide element of the quick connect fitting. For example, the dialyzer mount may include a pair of keyhole features with each keyhole feature having an upper insertion area sized to receive a portion of the base of the quick-connect fitting inserted into the upper insertion area, and a lower flanged portion having a width that is smaller than an overall a width of the base of the quick-connect fitting and that engages with a groove on the quick connect fitting. The lower flanged portion may include a pair of opposite flanges that engage with the groove and allow the quick-connect fitting to slide along the flanges.
In one embodiment, the bottom keyhole feature may include an adjustable support that is moveable in a vertical direction. For example, the adjustable support may be movable along the opposed flanges. Thus, the adjustable support may be fixable in a plurality of different positions on the flanges to support the weight of the dialyzer. In one arrangement, the adjustable support includes a “U” shaped member and at least one thumb screw that may be tightened to fix the “U” shaped member in place.
In another aspect of the invention, a blood line connector for a blood circuit of a hemodialysis unit may have the ability to make two different types of fluid tight connections, e.g., a screw-type connection with a luer connector at a patient access and a press-in type connection with a dialysate circuit of the hemodialysis unit. For example, the blood line connector may include a tube connection end arranged to sealingly engage with a blood circuit tube, and a patient access connection end with a frustoconical member having an internally threaded portion arranged to engage with an externally threaded patient access, and a pair of locking arms extending rearwardly from the frustoconical member. The locking arms may each have a finger depression portion and a barbed portion, and may be arranged to engage with a mating connector on the dialysis unit at the barbed portions to lock the frustoconical member in sealing engagement with the mating connector when making a press-in type connection. The barbed portions may disengage from the mating connector when the finger depression portions are urged toward each other. In one embodiment, the patient access connection end may include a central tube extending from the center of the frustoconical member. The internally threaded portion of the frustoconical member and the central tube may be arranged to mate with a female luer-type patient access connector or any other suitable screw-type connection.
In another aspect of the invention, a method for operating a dialysis unit includes connecting blood line connectors of arterial and venous blood lines for a dialysis unit to patient access connectors in communication with a patient blood system. In one embodiment, the patient access connectors may require a corresponding blood line connector to establish a threaded engagement with the patient access connector, thereby forming a luer or screw-type connection between the blood line connectors and the patient access connectors. The dialysis unit may be operated to withdraw blood from a patient access connector and into an arterial blood line, subject the withdrawn blood to a dialysis process to produce treated blood, and return the treated blood to the patient via the venous blood line and the other patient access connector. Thereafter, the blood line connectors may be disconnected from the patient access connectors by unscrewing the blood line connectors from a corresponding patient access connector, and the blood line connectors may be connected to a directing circuit of the dialysis unit. The blood line connectors may be connected to the directing circuit by a press-in connection with a corresponding connection point on the dialysis unit, e.g., by pushing the blood line connectors into the connection points to establish the press-in connection.
In another aspect of the invention, a reagent supply arrangement for a hemodialysis system may be arranged to provide two or more reagent materials for use in preparing a dialysate and may include a connector arranged to help prevent the connection of a reagent material to the wrong port. For example, the reagent supply may include an E-prong connector having three parallel prongs with two outer prongs arranged in a common plane and a center prong arranged above the common plane, a first supply line for a first reagent connected in fluid communication with one of the outer prongs, a second supply line for a second reagent connected in fluid communication with the other of the outer prongs, a liquid line connected in fluid communication with the center prong, and a container for housing the first reagent having an inlet connected to the liquid line and an outlet connected to the first supply line for the first reagent. The E-prong connector may help prevent the improper connection of the first and second supply lines to the dialysis unit, e.g., because the central prong being located out of the plane of the two outer prongs ensure connection of the E-prong connector in only one way to the dialysis unit.
In one embodiment, the container includes a bicarbonate material suitable for use in generating a dialysate for the hemodialysis system. The liquid line may be a water supply line that provides water to the container, allowing the water to mix with the bicarbonate (which may be in powder or other solid form) and flow to the first supply line. The second supply line may be an acid supply line that includes a connector and provides acid material to the E-prong connector. The reagent supply may also include an acid bag spike that is removably engaged with the connector of the acid supply line. The acid bag spike may include a spike member and a pair of spring clips at an end of the acid bag spike opposite the connector of the acid supply line, allowing the acid bag spike to be fluidly connected with an acid bag or other acid source.
In another aspect of the invention, a method for operating a hemodialysis system includes providing a dialysis unit having an enclosure containing suitable components for performing hemodialysis including a dialyzer, one or more pumps to circulate blood through the dialyzer, a source of dialysate, and one or more pumps to circulate the dialysate through the dialyzer. The enclosure may include a housing that supports the components and has a front panel at which blood circuit connections and dialysate fluidic connections are made. A reagent supply may be provided including an E-prong connector, a first supply line for a first reagent connected in fluid communication with one of the outer prongs, a second supply line for a second reagent connected in fluid communication with the other of the outer prongs, a liquid line connected in fluid communication with the center prong, and a container for housing the first reagent having an inlet connected to the liquid line and an outlet connected to the first supply line for the first reagent. The E-prong connector may be engaged with a connection point at the front panel of the dialysis unit, thereby allowing the dialysis unit to provide water to the liquid line of the reagent supply, and allowing the dialysis unit to receive the first and second reagents from the first and second supply lines.
Other advantages and novel features of the present invention will become apparent from the following detailed description of various non-limiting embodiments of the invention when considered in conjunction with the accompanying figures. In cases where the present specification and a document incorporated by reference include conflicting and/or inconsistent disclosure, the present specification shall control. If two or more documents incorporated by reference include conflicting and/or inconsistent disclosure with respect to each other, then the document having the later effective date shall control.
Aspects of the invention are described with reference to illustrative embodiments, which are described with reference to the drawings in which like numerals reference like elements, and wherein:
Various aspects of the invention are generally directed to new systems for hemodialysis and the like, such as hemofiltration systems, hemodiafiltration systems, plasmapheresis systems, etc. Accordingly, although the various systems and methods described herein are described in relation to hemodialysis, it should be understood that the various systems and method described herein are applicable to other dialysis systems and/or in any extracorporeal system able to treat blood or other bodily fluids, such as plasma.
As discussed below, a hemodialysis system typically includes a blood flow path and a dialysate flow path. It should be noted that within such flow paths, the flow of fluid is not necessarily linear, and there may be any number of “branches” within the flow path that a fluid can flow from an inlet of the flow path to an outlet of the flow path. Examples of such branching are discussed in detail below. In the blood flow path, blood is drawn from a patient, and is passed through a dialyzer, before being returned to the patient. The blood is treated by the dialyzer, and waste molecules (e.g., urea, creatinine, etc.) and water are passed from the blood, through a semi-permeable membrane in the dialyzer, into a dialysate solution that passes through the dialyzer by the dialysate flow path. In various embodiments, blood may be drawn from the patient from two lines (e.g., an arterial line and a venous line, i.e., “dual needle” flow), or in some cases, blood may be drawn from the patient and returned through the same or catheter needle (e.g., the two lines or lumens may both be present within the same needle, i.e., a form of “dual lumen” flow). In still other embodiments, a “Y” site or “T” site is used, where blood is drawn from the patient and returned to the patient through one patient connection having two branches (one being the fluid path for the drawn blood, the second the fluid path for the return blood, i.e., a form of “single needle” flow). The patient may be any subject in need of hemodialysis or similar treatments, including non-human subjects, such as dogs, cats, monkeys, and the like, as well as humans.
In the dialysate flow path, fresh dialysate is prepared and is passed through the dialyzer to treat the blood from the blood flow path. The dialysate may also be equalized for blood treatment within the dialyzer (i.e., the pressure between the dialysate and the blood are equalized), often exactly, or in some embodiments, at least within about 1% or about 2% of the pressure of the blood. In some cases, it may be desirable to maintain a greater pressure difference (either positive or negative) between the blood flow path and dialysate flow path. After passing through the dialyzer, the used dialysate, containing waste molecules (as discussed below), is discarded in some fashion. The dialysate in some cases may be re-circulated in a “multi-pass” arrangement, which may be beneficial in capturing larger molecules having low mobility across the dialyzer. In some cases, the dialysate is heated prior to treatment of the blood within the dialyzer using an appropriate heater, such as an electrical resistive heater. The dialysate may also be filtered to remove contaminants, infectious organisms, debris, and the like, for instance, using an ultrafilter. The ultrafilter may have a pore size chosen to prevent species such as these from passing therethrough. For instance, the pore size may be less than about 0.3 micrometers, less than about 0.2 micrometers, less than about 0.1 micrometers, or less than about 0.05 micrometers, etc. The dialysate is used to draw waste molecules (e.g., urea, creatinine, ions such as potassium, phosphate, etc.) and water from the blood into the dialysate through osmosis or convective transport, and dialysate solutions are well-known to those of ordinary skill in the art.
The dialysate typically contains various ions such as sodium, chloride, bicarbonate, potassium and calcium that are similar in concentration to that of normal blood. In some cases, the bicarbonate, may be at a concentration somewhat higher than found in normal blood. Typically, the dialysate is prepared by mixing water from a water supply with one or more ingredients: an “acid” (which may contain various species such as acetic acid, dextrose, NaCl, CaCl, KCl, MgCl, etc.), sodium bicarbonate (NaHCO3), and/or sodium chloride (NaCl). The preparation of dialysate, including using the appropriate concentrations of salts, osmolarity, pH, and the like, is well-known to those of ordinary skill in the art. As discussed in detail below, the dialysate need not be prepared at the same rate that the dialysate is used to treat the blood. For instance, the dialysate can be made concurrently or prior to dialysis, and stored within a dialysate storage vessel or the like.
Within the dialyzer, the dialysate and the blood typically are separated by a semi-permeable membrane. Typically, the semipermeable membrane is formed from a polymer such as cellulose, polyarylethersulfone, polyamide, polyvinylpyrrolidone, polycarbonate, polyacrylonitrile, or the like, which allows the transport of ions or small molecules (e.g., urea, water, etc.), but does not allow bulk transport or convection during treatment of the blood. In some cases (such as high-flux dialyzers), even larger molecules, such as beta-2-microglobulin, may pass through the membrane. In some cases, for example, ions and molecules may pass through the dialyzer by convective flow if a hydrostatic pressure difference exists across the semi-permeable membrane. It should be noted that, as used herein, “fluid” means anything having fluidic properties, including but not limited to, gases such as air, and liquids such as water, aqueous solution, blood, dialysate, etc.
The blood flow circuit 141 includes an anticoagulant supply 11 and a blood flow pump 13 which pumps blood from a patient through a dialyzer 14 and returns the blood to the patient. The anticoagulant supply 11, although shown in the path of blood flowing towards the dialyzer, may be instead located in another suitable location. e.g., any location upstream or downstream from blood flow pump 13. The balancing circuit 143 includes two dialysate pumps 15, which pump dialysate into the dialyzer 14, and a bypass pump 35. The flow of blood through the blood flow circuit 141 in some cases, is synchronized with the flow of dialysate in the dialysate flow path. In an embodiment, the flow of dialysate into and out of the dialyzer 14 and the balancing circuit 143 is balanced volumewise using balancing chambers in the balancing circuit 143. The directing circuit 142 includes a dialysate pump 159, which pumps dialysate from a dialysate tank 169 through a heater 72 and/or the ultrafilter 73 to the balancing circuit 143. The directing circuit 142 also receives waste fluid from balancing circuit 143 and directs it to a drain 31. In some cases, the blood flow circuit 141 can be connected via conduits 67 to the directing circuit 142, e.g., for disinfection, as discussed below. Dialysate in the dialysate tank 169 is provided by the mixing circuit 25, which produces the dialysate using water from a water supply 30 provided via the directing circuit 142 and dialysate ingredients 49 (e.g., bicarbonate and acid). A series of mixing pumps 180, 183, 184 are used to mix the various components and produce the dialysate.
For example, in one embodiment, the blood flow pump 13 may comprise two (or more) pod pumps 23. Each pod pump, in this particular example, may include a rigid chamber with a flexible diaphragm or membrane dividing each chamber into a pumping compartment and control compartment. There may be four entry/exit valves for these compartments, two for the pumping compartment and two for the control compartment. The valves for the control compartment of the chambers may be two-way proportional valves, one connected to a first control fluid source (e.g., a high pressure air source), and the other connected to a second control fluid source (e.g., a low pressure air source) or a vacuum source. The fluid valves can be opened and closed to direct fluid flow when the pod pumps 23 are operating. Non-limiting examples of pod pumps are described in U.S. Provisional Application 60/792,073, filed Apr. 14, 2006, or in U.S. patent application Ser. No. 11/787,212, filed Apr. 13, 2007 and issued as U.S. Pat. No. 8,292,594 on Oct. 23, 2012, each incorporated herein by reference. If more than one pod pump is present, the pod pumps may be operated in any suitable fashion, e.g., synchronously, asynchronously, in-phase, out-of-phase, etc. For instance, in some embodiments, the two-pump pumps can be cycled out of phase to affect the pumping cycle, e.g., one pump chamber fills while the second pump chamber empties. A phase relationship anywhere between 0° (the pod pumps fill and empty in unison) and 180° (one pod pump fills as the other empties) can be selected in order to impart any desired pumping cycle. A phase relationship of 180° may yield continuous flow into and out of the set of pod pumps. This is useful, for instance, when continuous flow is desired, e.g., for use with dual needle or dual lumen catheter flow. Setting a phase relationship of 0°, however, may be useful in some cases for single needle/single lumen flow or in other cases. In a 0° relationship, the pod pumps will first fill from the needle, then deliver blood through the blood flow path and back to the patient using the same needle. In addition, running at phases between 0° and 180° can be used in some cases, to achieve a push/pull relationship (hemodiafiltration or continuous back flush) across the dialyzer. An anticoagulant (e.g., heparin, or any other suitable anticoagulant) may be contained within a vial 11 (or other anticoagulant supply, such as a tube or a bag), and blood flow circuit 141 may include a spike 201 (which, in one embodiment, is a needle) that can pierce the seal of the vial. The spike 201 may be formed from plastic, stainless steel, or another suitable material, and may be a sterilizable material in some cases, e.g., the material may be able to withstand sufficiently high temperatures and/or radiation so as to sterilize the material.
An anticoagulant pump 80, which can act as a metering chamber in some cases, can be used to control the flow of anticoagulant into the blood circuit. The anticoagulant pump 80 may be a pod pump or a membrane-based metering pump, and/or may be actuated by a control fluid, such as air. For example, the anticoagulant pump 80 may include a rigid chamber with a flexible diaphragm dividing the chamber into a pumping compartment and a control compartment. One valve for the control compartment of the chamber may be connected to a first control fluid source (e.g., a high pressure air source), and the other valve connected to a second control fluid source (e.g., a low pressure air source) or a vacuum source. Valves for the pumping compartment of the chamber can be opened and closed in coordination with the control compartment, thus controlling the flow of anticoagulant into the blood. In one set of embodiments, air provided through a filter 81 may also be introduced into the blood flow path by the anticoagulant pump 80, e.g., to provide air into the vial 11 after or before anticoagulant is withdrawn from the vial.
Fluid Management System (“FMS”) measurements may be used to measure the volume of fluid pumped through a pump chamber during a stroke of the membrane, or to detect air in the pumping chamber. FMS methods are described in U.S. Pat. Nos. 4,808,161; 4,826,482; 4,976,162; 5,088,515; and 5,350,357, which are hereby incorporated herein by reference in their entireties. In one illustrative embodiment, the volume of liquid delivered by an anticoagulant pump, a dialysate pump, or other membrane-based fluid pump is determined using an FMS algorithm in which changes in chamber pressure are used to calculate a volume measurement at the end of a fill stroke and at the end of a delivery stroke. The difference between the computed volumes at the end of fill and delivery strokes may be used to determine the actual stroke volume. This actual stroke volume can be compared to an expected stroke volume for the particular sized chamber. If the actual and expected volumes are significantly different, the stroke has not properly completed and an error message can be generated.
The blood flow circuit 141 may also include an air trap 19 to remove air bubbles that may be present within the blood flow path. In some cases, the air trap 19 is able to separate any air that may be present from the blood due to gravity, and/or may include a port for sampling blood.
In one embodiment, balancing of flow in the internal dialysate circuit works as follows. A set of pneumatically operated valves 211, 212, 213, 241, 242 has its operation synchronized and controlled together, where valves 211, 212, 213 are ganged and valves 241 and 242 are ganged, and a second set of pneumatically operated valves 221, 222, 223, 231, 232 similarly have its operation synchronized and controlled together, where valves 221, 222, 223 are ganged, and valves 231 and 232 are ganged. At a first point of time, the first set of valves 211, 212, 213, 241, 242 is opened while the second set of valves 221, 222, 223, 231, 232 is closed. Fresh dialysate flows into balancing chamber 341 while used dialysate flows from dialyzer 14 into pod pump 161. Fresh dialysate does not flow into balancing chamber 342 since valve 221 is closed. As fresh dialysate flows into balancing chamber 341, used dialysate within balancing chamber 341 is forced out and exits balancing circuit 143 (the used dialysate cannot enter pod pump 161 since valve 223 is closed). Simultaneously, pod pump 162 forces used dialysate present within the pod pump into balancing chamber 342 (through valve 213, which is open; valves 242 and 222 are closed, ensuring that the used dialysate flows into balancing chamber 342). This causes fresh dialysate contained within balancing chamber 342 to exit the balancing circuit 143 into dialyzer 14. Also, pod pump 161 draws in used dialysate from dialyzer 14 into pod pump 161.
Once pod pump 161 and balancing chamber 341 have filled with dialysate, the first set of valves 211, 212, 213, 241, 242 is closed and the second set of valves 221, 222, 223, 231, 232 is opened. Fresh dialysate flows into balancing chamber 342 instead of balancing chamber 341, as valve 212 is closed while valve 221 is now open. As fresh dialysate flows into balancing chamber 342, used dialysate within the chamber is forced out and exits balancing circuit, since valve 213 is now closed. Also, pod pump 162 now draws used dialysate from the dialyzer into the pod pump, while used dialysate is prevented from flowing into pod pump 161 as valve 232 is now closed and valve 222 is now open. Pod pump 161 forces used dialysate contained within the pod pump (from the previous step) into balancing chamber 341, since valves 232 and 211 are closed and valve 223 is open. This causes fresh dialysate contained within balancing chamber 341 to be directed into the dialyzer 14 (since valve 241 is now open while valve 212 is now closed). At the end of this step, pod pump 162 and balancing chamber 342 have filled with dialysate. This puts the state of the system back into the configuration at the beginning of this description, and the cycle is thus able to repeat, ensuring a constant flow of dialysate to and from the dialyzer 14. In an embodiment, the fluid (e.g. pneumatic) pressures on the control side of the balancing chamber valves are monitored to ensure they are functioning (e.g., opening and closing) properly.
As a specific example, a vacuum (e.g., 4 p.s.i. of vacuum) can be applied to the port for the first set of valves, causing those valves to open, while positive pressure (e.g., 20 p.s.i. of air pressure) is applied to the second set of valves, causing those valves to close (or vice versa). The pod pumps each urge dialysate into one of the volumes in one of the balancing chambers 341, 342. By forcing dialysate into a volume of a balancing chamber, an equal amount of dialysate is squeezed by the diaphragm out of the other volume in the balancing chamber. In each balancing chamber, one volume is occupied by fresh dialysate heading towards the dialyzer and the other volume is occupied by used dialysate heading from the dialyzer. Thus, the volumes of dialysate entering and leaving the dialyzer are kept substantially equal.
The bypass pump 35 can direct the flow of dialysate from the dialyzer 14 through balancing circuit 143 without passing through either of pod pumps 161 or 162. In this embodiment, the bypass pump 35 is a pod pump, similar to those described above, with a rigid chamber and a flexible diaphragm dividing each chamber into a fluid compartment and a control compartment. This pump may be the same or different from the other pod pumps and/or metering pumps described above. When control fluid is used to actuate the bypass pump 35, the additional drop in pressure on the exiting (spent) dialysate side of the dialyzer causes additional ultrafiltration of fluid from the blood in the dialyzer. This may cause a net efflux of fluid from the patient's blood, through the dialyzer, and ultimately to drain. Such a bypass may be useful, for example, in reducing the amount of fluid a patient has, which is often increased due to the patient's inability to excrete excess fluid (primarily water) through the kidneys. As shown in
To achieve balanced flow across the dialyzer, the blood flow pump, the pumps of the balancing circuit, and the pumps of the directing circuit (discussed below) may be operated to work together to ensure that flow into the dialyzer is generally equal to flow out of the dialyzer. If ultrafiltration is required, the ultrafiltration pump (if one is present) may be run independently of some or all of the other blood and/or dialysate pumps to achieve the desired ultrafiltration rate.
To prevent outgassing of the dialysate, the pumps of the balancing circuit may be kept at pressures above atmospheric pressure. In contrast, however, the blood flow pump and the directing circuit pumps use pressures below atmosphere to pull the diaphragm towards the chamber wall to complete a fill stroke. Because of the potential of fluid transfer across the semi-permeable membrane of the dialyzer and because the pumps of the balancing circuit run at positive pressures, the balancing circuit pumps may be able to use information from the blood flow pump(s) in order to synchronize the delivery strokes of the balancing circuit chambers to the dialyzer with the delivery strokes of the blood pumps.
In one set of embodiments, when running in such a balanced mode, if there is no delivery pressure from the blood flow pump, the balancing circuit pump diaphragm will push fluid across the dialyzer into the blood and the alternate pod of the balancing circuit will not completely fill. For this reason, the blood flow pump reports when it is actively delivering a stroke. When the blood flow pump is delivering a stroke the inside dialysate pump operates. When the blood flow pump is not delivering blood, the valves that control the flow from the dialyzer to the inside dialysate pumps (and other balancing valves ganged together with these valves, as previously discussed) may be closed to prevent any fluid transfer from occurring from the dialysate side to the blood side. During the time the blood flow pump is not delivering, the inside dialysate pumps are effectively frozen, and the inside dialysate pump delivery stroke resumes once the blood flow pump starts delivering again. The inside dialysate pump fill pressure can be set to a minimal positive value to ensure that the pump operates above atmosphere at minimal impedance. Also, the inside dialysate pump delivery pressure can be set to the blood flow pump pressure to generally match pressures on either side of the dialyzer, minimizing flow across the dialyzer during delivery strokes of the inside dialysate pump.
In another embodiment, the inside dialysate pump delivers dialysate to the dialyzer at a pressure slightly above the pressure at which blood is delivered to the dialyzer. This ensures that a full balance chamber of clean dialysate gets delivered to the dialyzer. On the return side, the inside dialysate pump can fill with spent dialysate from the dialyzer at a slightly lower pressure than the outlet pressure on the blood side of the dialyzer, ensuring that the receiving dialysate pump chamber can fill. This in turn ensures that there is enough dialysate available to complete a full stroke in the balancing chamber. Flows across the semi-permeable membrane caused by these differential pressures will tend to cancel each other; and the pumping algorithm otherwise attempts to match the average pressures on the dialysate and blood sides of the dialyzer.
It is generally beneficial to keep the blood flow as continuous as possible during therapy, as stagnant blood flow can result in blood clots. In addition, when the delivery flow rate on the blood flow pump is discontinuous, the balancing pump may pause its stroke more frequently, which can result in discontinuous and/or low dialysate flow rates. However, the flow through the blood flow pump can be discontinuous for various reasons. For instance, pressure may be limited within the blood flow pump, e.g., to +600 mmHg and/or −350 mmHg to provide safe pumping pressures for the patient. For instance, during dual needle flow, the two pod pumps of the blood flow pump can be programmed to run 180° out of phase with one another. If there were no limits on pressure, this phasing could always be achieved. However to provide safe blood flow for the patient these pressures are limited. If the impedance is high on the fill stroke (due to a small needle, very viscous blood, poor patient access, etc.), the negative pressure limit may be reached and the fill flow rate will be slower then the desired fill flow rate. Thus the delivery stroke must wait for the previous fill stroke to finish, resulting in a pause in the delivery flow rate of the blood flow pump. Similarly, during single needle flow, the blood flow pump may be run at 0° phase, where the two blood flow pump pod pumps are simultaneously emptied and filled. When both pod pumps are filled, the volumes of the two pod pumps are delivered. In an embodiment, the sequence of activation causes a first pod pump and then a second pod pump to fill, followed by the first pod pump emptying and then the second pod pump emptying. Thus the flow in single needle or single lumen arrangement may be discontinuous.
One method to control the pressure saturation limits would be to limit the desired flow rate to the slowest of the fill and deliver strokes. Although this would result in slower blood delivery flow rates, the flow rate would still be known and would be more continuous, which would allow for more accurate and continuous dialysate flow rates. Another method to make the blood flow rate more continuous in single needle operation would be to use maximum pressures to fill the pods so the fill time would be minimized. The desired deliver time could then be set to be the total desired stroke time minus the time that the fill stroke took. However, the less continuous the blood flow, the more the dialysate flow rate may have to be adjusted upward during blood delivery to the dialyzer to make up for the time that the dialysate pump is stopped when the blood flow pump is filling. If this is done with the correct timing, an average dialysate flow rate taken over several strokes can still match the desired dialysate flow rate.
The flow of dialysate through the directing circuit 142 may be controlled (at least in part) by operation of the dialysate pump 159. In addition, the dialysate pump 159 may control flow through the balancing circuit 143. For instance, as discussed above, fresh dialysate from the directing circuit 142 flows into balancing chambers 341 and 342 of balancing circuit 143. The dialysate pump 159 may be used as a driving force to cause the fresh dialysate to flow into these balancing chambers. In one set of embodiments, dialysate pump 159 includes a pod pump, e.g., similar to those described above.
The dialysate may also be filtered to remove contaminants, infectious organisms, pathogens, pyrogens, debris, and the like, for instance, using an ultrafilter 73. The ultrafilter 73 may be positioned in any suitable location in the dialysate flow path, for instance, between the directing circuit and the balancing circuit, e.g., as shown, and/or the ultrafilter 73 may be incorporated into the directing circuit or the balancing circuit. If an ultrafilter is used, its pore size may be chosen to prevent species such as these from passing through the filter.
In some cases, the ultrafilter 73 may be operated such that waste from the filter (e.g., the retentate stream) is passed to a waste stream, such as waste line 39 in
The ultrafilter and the dialyzer may provide redundant screening methods for the removal of contaminants, infectious organisms, pathogens, pyrogens, debris, and the like. Accordingly, any contaminant would have to pass through both the ultrafilter and the dialyzer before reaching a patient's blood. Even in the event that either the ultrafilter or dialyzer integrity fails, the other may still be able to maintain dialysate sterility and prevent contaminants from reaching the patient's blood.
The directing circuit 142 may also be able to route used dialysate coming from a balancing circuit to a drain, e.g., through waste line 39 to drain 31. The drain may be, for example, a municipal drain or a separate container for containing the waste (e.g., used dialysate) to be properly disposed of. In some cases, one or more check or “one-way” valves (e.g., check valves 215 and 216) may be used to control flow of waste from the directing circuit 142 and from the system 5. Also, in certain instances, a blood leak sensor (e.g., sensor 258) may be used to determine if blood is leaking through the dialyzer 14 into the dialysate flow path. In addition, a liquid sensor can be positioned in a collection pan at the bottom of the hemodialysis unit to indicate leakage of either blood or dialysate, or both, from any of the fluid circuits.
The directing circuit 142 may receive water from a water supply 30, e.g., from a container of water such as a bag, and/or from a device able to produce water, e.g., a reverse osmosis device. In some cases, the water entering the system is set at a certain purity, e.g., having ion concentrations below certain values. The water entering into the directing circuit 142 may be passed on to various locations, e.g., to a mixing circuit 25 for producing fresh dialysate and/or to waste line 39. In some cases, valves to the drain 31 and various recycle lines are opened, and conduits 67 may be connected between directing circuit 142 and blood flow circuit 141, such that water is able to flow continuously around the system. If heater 72 is also activated, the water passing through the system will be continuously heated, e.g., to a temperature sufficient to disinfect the system.
The power unit 52 housing may contain suitable components for providing operating power to the dialysis unit 51, e.g., pneumatic pressure/vacuum to power the pumps, valves and other components of the dialysis unit 51. “Pneumatic,” as used herein, means using air or other gas to move a flexible diaphragm or other member. (It should be noted that air is used by way of example only, and in other embodiments, other control fluids, such as nitrogen (N2), CO2, water, an oil, etc., may be used). As discussed above, the pumps and valves of the dialysis unit 51 may operate on pneumatic power, and thus the power unit 52 may provide one or more pneumatic sources for use by the dialysis unit 51. In this way, the dialysis unit 51 need not necessarily be arranged to generate and/or store the necessary pneumatic power needed, but instead may rely on the power unit module 52. The power unit 52 may include one or more pneumatic pumps to generate desired air pressure and/or vacuum, one or more accumulators or other devices to store pneumatic power, valves, conduits and/or other devices to control flow of pneumatic power in the power unit 52, as well as a controller having suitable components, such as a programmed general purpose data processor, memory, sensors (e.g., to detect pressure, temperature, etc.), relays, actuators, and so on. In one embodiment, the pneumatic power (e.g., air under suitable pressure/vacuum) may be supplied by the power unit 52 to the dialysis unit 51 via one or more supply tanks or other pressure sources. For instance, if two tanks are used in the power unit 52, one supply tank may be a positive pressure reservoir, and in one embodiment, has a set point of 750 mmHg (gauge pressure) (1 mmHg is about 133.3 pascals). The other supply tank can be a vacuum or negative pressure reservoir, and in one embodiment, has a set point of −450 mmHg (gauge pressure). This pressure difference may be used, for instance, between the supply tanks and the required pod pump pressure to allow for accurate control of the variable valves to the pod pumps. The supply pressure limits can be set based on maximum pressures that can be set for the patient blood flow pump plus some margin to provide enough of a pressure difference for control of the variable valves. Thus, in some cases, the two tanks may be used to supply pressures and control fluids for all of the dialysis unit 51 functions.
In one embodiment, the power unit 52 may include two independent compressors to service the supply tanks. Pressure in the tanks can be controlled using any suitable technique, for instance, with a simple “bang-bang” controller (a controller that exists in two states, i.e., in an on or open state, and an off or closed state), or with more sophisticated control mechanisms, depending on the embodiment. As an example of a bang-bang controller, for the positive tank, if the actual pressure is less than a set point, the compressor servicing the positive tank is turned on. If the actual pressure is greater than a set point, the compressor servicing the positive tank is turned off. The same logic may be applied to the vacuum tank and control of the vacuum compressor with the exception that the sign of the set point term is reversed. If the pressure tanks are not being regulated, the compressor is turned off and the valves are closed.
Tighter control of the pressure tanks can be achieved by reducing the size of the hysteresis band, however this may result in higher cycling frequencies of the compressor. If very tight control of these reservoirs is required, the bang-bang controller could be replaced with a proportional-integral-derivative (“PID”) controller and using pulse width modulation (“PWM”) signals on the compressors. Other methods of control are also possible.
Other pressure sources may be used in other embodiments, and in some cases, more than one positive pressure source and/or more than one negative pressure source may be used. For instance, more than one positive pressure source may be used that provides different positive pressures (e.g., 1000 mmHg and 700 mmHg), which may be used to minimize leakage. For example, high positive pressure can be used to control valves, whereas lower positive pressures can be used to control pumps. This limits the amount of pressure that can potentially be sent to the dialyzer or to the patient, and helps to keep actuation of the pumps from overcoming the pressures applied to adjacent valves. A non-limiting example of a negative pressure is −400 mmHg. In some cases, the negative pressure source may be a vacuum pump, while the positive pressure pump may be an air compressor.
Moreover, the power unit 52 may be selectively connectable to the dialysis unit 51, e.g., to allow different power units 52 to be interchanged. For example, the dialysis unit 51 may be arranged to work with different types of power units 52, such as power units 52 that use electrical power to generate the pneumatic power supply, as well as power units 52 that use stored pneumatic power (e.g., pressurized air stored in one or more high pressure tanks). Thus, a power unit 52 may be interchanged for another unit 52, in case of failure or other requirements. For example, it may be desired to use the system 5 in an area where noise generation is unacceptable, such as when nearby people are sleeping. In this case, it may be desirable to use a power unit 52 that uses stored pneumatic power, rather than a unit 52 that generates pneumatic power by running pumps or other noise generating equipment. As shown in
The dialysis unit 51 may include a controller to control flow of control fluid for various components of the system 5, as well as perform other desired functions. In some cases, the control fluid may be held at different pressures within the various tubes or conduits. For instance, some of the control fluid may be held at positive pressure (i.e., greater than atmospheric pressure), while some of the control fluid may be held at negative pressures (less than atmospheric pressure). In addition, in certain embodiments, the controller may have components that are kept separate from the various liquid circuits. This configuration has a number of advantages. For example, in one embodiment, the liquid circuits in the dialysis unit 51 may be heated to disinfection temperatures and/or exposed to relatively high temperatures or other harsh conditions (e.g., radiation) to effect disinfection, while electronic components of the controller may not be exposed to such harsh conditions, and may even be kept separate by an insulating wall (e.g., a “firewall”) or the like. That is, the dialysis unit housing may have two or more compartments, e.g., one compartment with electronic and other components that may be sensitive to heat or other conditions, and another compartment with liquid circuit components that are heated or otherwise treated for disinfection.
Thus, in some embodiments, the system 5 may include a “cold” section (which is not heated), and a “hot” section, portions of which may be heated, e.g., for disinfection purposes. The cold section may be insulated from the hot section through insulation. In one embodiment, the insulation may be molded foam insulation, but in other embodiments can be any type of insulation, including but not limited to a spray insulation, an air space, insulation cut from sheets, etc. In one embodiment, the cold section includes a circulation system, e.g., a fan and/or a grid to allow air to flow in and out of the cold box. In some cases, the insulation may be extended to cover access points to the “hot” section, e.g., doors, ports, gaskets, and the like. For instance, when the “hot” section is sealed, the insulation may completely surround the “hot” section in some cases.
Non-limiting examples of components that may be present within the “cold” section include power supplies, electronics, power cables, pneumatic controls, or the like. In some cases, at least some of the fluids going to and from the “hot” section may pass through the “cold” section; however, in other cases, the fluids may pass to the “hot” section without passing through the “cold” section.
Non-limiting examples of components that may be present within the “hot” section include cassettes (if present), fluid lines, temperature and conductivity sensors, blood leak sensors, heaters, other sensors, switches, emergency lights, or the like. In some cases, some electrical components may also be included in the “hot” section. These include, but are not limited to, a heater. In one embodiment, the heater can be used to heat the hot box itself, in addition to fluid. In some embodiments, the heater 72 heats the entire “hot” section to reach a desired temperature.
In accordance with an aspect of the invention, the dialysis unit 51 housing may include vertical side-by-side doors that can be opened to expose all mechanical interface points for blood flow circuitry and connections for dialysate circuitry, i.e., all connection points for patient blood connections and acid/bicarbonate connections, that must be made by a user to use the dialysis unit 51.
In this embodiment, the doors 53 are connected to the dialysis unit 51 housing by a dual hinge arrangement such that the doors 53 can be opened to two different states of opening.
Although magnets are used in this illustrative embodiment as part of a retainer member to help the doors 53 and/or hinge plates 533 stay in a particular state of opening or closing, other arrangements for a retainer member are possible. For example, the hinge connection between the doors 53 and the hinge plates 533 and/or the connection between the hinge plates 533 and the housing 51 may include a detent arrangement that serves to resiliently hold the door 53 or hinge plate 533 in a particular position relative to the other part (the hinge plate or housing, respectively). In another embodiment, one or more springs may be used to help maintain the doors 53 in an open position relative to the hinge plates 533. In yet another embodiment, the hinge plates 533 may have a friction or interference fit with a portion of the housing 51 that tends to maintain the hinge plates 533 in the closed position (adjacent the housing). Accordingly, a retainer member that functions to help maintain a door 53 in a particular position relative to its hinge plate 533, and/or that functions to help maintain a hinge plate 533 in a particular position relative to the housing 51, may take any one of a number of possible arrangements.
In accordance with another aspect of the invention, opening of the doors to the dialysis unit housing may reveal all of the user-made connections for blood circuit connections and dialysate fluidic connections needed for operation of the system 5. For example, as shown in
Also exposed on the front panel 511 is a user control panel 510. The user control panel 510 includes one or more buttons permitting the user to bypass the graphical user interface on control interface 55, providing an alternate method to control certain functions (e.g., critical functions) during hemodialysis. This may be important, for example, if the control interface 55 should ever fail during a dialysis treatment session. Non-limiting examples of critical functions can include a “stop dialysis” or “pause dialysis” command and an “infuse dialysate solution” command.
In an embodiment, a self-sealing port, such as a self-sealing stopper with a split septum or membrane, or another arrangement, is located at the top of the trap, allowing the withdrawal of air from the container (e.g., by syringe). The blood-side surface of the self-sealing membrane can be situated nearly flush with the top of the interior of the trap, in order to facilitate cleaning of the self-sealing port during disinfection, e.g., by reversing flow through the air trap using a dialysate or other cleaning fluid. Also, the inlet, outlet and internal wall of the container and the self-sealing port may be arranged to substantially eliminate stagnation regions, i.e., allow for few or no regions where blood can stagnate or clot. The self-sealing port can also serve as a blood sampling site, and/or to allow the introduction of liquids, drugs or other compounds into the blood circuit. A sealed rubber-type stopper can be used if access with a needle is contemplated. Using a self-sealing stopper with split septum permits sampling and fluid delivery using a needleless system.
In accordance with another aspect of the invention, the front panel 511 includes a blood line wrap feature around the periphery of the front panel 511. In this illustrative embodiment, the front panel 511 includes flanged portions 518 along the top edge and at lower corners of the front panel 511. This allows a user to wrap the blood lines 203, 204 around the periphery of the front panel 511 by placing the lines 203, 204 in a channel defined by the flanged portions 518. The lines 203, 204 may be wrapped in a clockwise direction, starting from a point near the bottom of the dialyzer 14, and ending at a point near the lower right corner of the front panel 511. The blood lines 203, 204 may then be connected at the blood line connection points 514, e.g., to allow disinfecting fluid to be circulated through the blood lines 203, 204. As a result, the blood lines 203, 204 can be neatly retained on the front panel 511, allowing easy access to other components on the front panel 511 and allowing the user to close the doors 53 with minimal concern for pinching the blood lines 203, 204 between the doors 53 and the dialyzer unit housing 51. Alternatively, the blood lines 203, 204 may be first connected at the blood line connection points 514, and then wrapped in a clockwise direction, starting from a point near the bottom of the dialyzer 14, and ending at a point near the lower right corner of the front panel 511. This ensures that the blood lines are properly distributed along the flanged portions 518 to reach the connection points 514. Vertical fences 519 may also be provided along the left and right sides of the front panel 511 to help keep the blood lines 203, 204 in a desired position and away from the hinge plates 533 and other possible pinch points.
In accordance with another aspect of the invention, the front panel 511 of the dialysis unit 51 (or other suitable component) may be arranged to accommodate a variety of differently sized and/or shaped dialyzer units 14. Different patients, and in some cases even the same patient over time, may be prescribed different dialyzers so as to provide different treatment conditions. Thus, the dialysis unit 51 is preferably arranged to operate with multiple different types of dialyzers 14. In many cases, different dialyzers 14 have different dimensions, such as the overall diameter and/or length of the dialyzer unit. In this illustrative embodiment as shown in
To mount the dialyzer 14 to the keyhole features 520, the quick connect fittings 14a may be partially inserted into the upper insertion area 520a of the top and bottom keyhole features, respectively, so that the groove 14d of each fitting 14a is aligned with a flange of the lower flanged portion 520b of the keyhole features 520. (Note that the upper insertion area 520 of the bottom keyhole feature 520 may be made longer than that shown in
In accordance with another aspect of the invention, one or both of the keyhole features 520 may be adjustable so that the weight of the dialyzer 14 is shared by both lower flanged portions 520b of the keyhole features 520. For example, in this illustrative embodiment, the bottom keyhole feature 520 has part of the lower flanged portion 520b adjustable in vertical position relative to the top keyhole feature 520. In this way, the portion of the lower flanged portion 520b may be adjusted in vertical position so that, with the top quick connect fitting 14a supported by the flanged portion 520b of the top keyhole feature 520, the movable portion of the flanged portion 520b of the bottom keyhole feature can be moved, e.g., upwardly, so that the bottom quick connect fitting 14a is also supported by the flanged portion 520b. Thus, the weight of the dialyzer 14 can be shared by both keyhole features 520. The flanged portion 520b may be made adjustable in any suitable way. In this embodiment, the flanged portion 520b has a “U” shaped member 520c that is vertically slidable along the vertical flanges and can be fixed in place by tightening a set of thumb screws. The “U” shaped member 520c may engage the quick connect fitting 14a so that the “U” shaped member 520c supports the weight (at least in part) of the dialyzer 14.
Although in the embodiment above, the dialyzer 14 is supported by keyhole features in the front panel 511, a support arrangement for the dialyzer may be configured in other ways. For example, the upper insertion area 520a is not necessarily required. Instead, only flange portions (e.g., in the shape of a “U” shaped flange having opposed flange portions) may be provided to engage the dialyzer quick connect fittings. The flange portions may be offset from the front surface of the front panel 511 to provide clearance for the fitting and allow the flange portions to engage with the grooves of the quick connect fittings. Also, the flange portions need not be provided in a vertical orientation as shown, but instead may be oriented at an angle to the vertical, e.g., in a horizontal arrangement. The flange portions may have a detent, catch, or other feature to help maintain the dialyzer in place as well.
In accordance with another aspect of the invention, a bicarbonate, acid and/or other reagent supply device may be selectively associated with the dialysis unit. As described above, the dialysis unit 51 requires a supply of certain chemicals to generate dialysate and/or other materials needed for system operation.
In accordance with another aspect of the invention, a disinfect connector (not shown) engages with connection point 512 for use during a disinfection procedure. The disinfect connector has three parallel prongs having a similar orientation as the E-prong connector 491, so that the prongs may engage with the receiving holes in connection point 512. The channels in the prongs of the disinfect connector terminate within a common chamber within the disinfect connector. Thus, during a disinfect procedure, the bicarbonate flow line, acid flow line and water flow line are all interconnected, permitting disinfection of each of these flow lines during the disinfect procedure. (This is shown as a dashed inverted “T” line at 49 in
In accordance with another aspect of the invention, the blood lines 203, 204 are equipped with a connector that enables two types of connections to be made. One type of connection is a plug-in or press-in connection by which the connector can be pushed into a receiving lumen and a leakfree connection made without requiring rotation of the connector or the receiving lumen. A second type of connection is a screw-type connection by which a leakfree connection can be made by a threaded engagement of the connector with a complementary element. For example,
While several embodiments of the present invention have been described and illustrated herein, those of ordinary skill in the art will readily envision a variety of other means and/or structures for performing the functions and/or obtaining the results and/or one or more of the advantages described herein, and each of such variations and/or modifications is deemed to be within the scope of the present invention. More generally, those skilled in the art will readily appreciate that all parameters, dimensions, materials, and configurations described herein are meant to be exemplary and that the actual parameters, dimensions, materials, and/or configurations will depend upon the specific application or applications for which the teachings of the present invention is/are used. Those skilled in the art will recognize, or be able to ascertain using no more than routine experimentation, many equivalents to the specific embodiments of the invention described herein. It is, therefore, to be understood that the foregoing embodiments are presented by way of example only and that, within the scope of the appended claims and equivalents thereto, the invention may be practiced otherwise than as specifically described and claimed.
The indefinite articles “a” and “an,” as used herein in the specification and in the claims, unless clearly indicated to the contrary, should be understood to mean “at least one.”
This application is a continuation of U.S. application Ser. No. 14/692,801, filed Apr. 22, 2015 and issued as U.S. Pat. No. 9,987,407 on Jun. 5, 2018, which is a continuation of U.S. application Ser. No. 12/199,077, filed Aug. 27, 2008 and issued as U.S. Pat. No. 9,028,691 on May 12, 2015, which is a continuation-in-part of prior U.S. application Ser. No. 12/072,908, filed Feb. 27, 2008 and issued as U.S. Pat. No. 8,246,826 on Aug. 21, 2012, which claims the benefit of U.S. Provisional Application Ser. No. 60/903,582, filed Feb. 27, 2007 and U.S. Provisional Application Ser. No. 60/904,024, filed Feb. 27, 2007. U.S. application Ser. No. 12/199,077 is a continuation-in-part of prior U.S. application Ser. No. 12/038,474, filed Feb. 27, 2008 and issued as U.S. Pat. No. 8,491,184 on Jul. 23, 2013, which is a continuation-in-part of prior U.S. application Ser. No. 11/871,821, filed Oct. 12, 2007 and published as U.S. Patent Application Publication No. 2008/0240929 on Oct. 2, 2008, now abandoned, which claims the benefit of U.S. Provisional Application Ser. No. 60/921,314, filed Apr. 2, 2007 and U.S. Provisional Application Ser. No. 60/904,024, filed Feb. 27, 2007. U.S. application Ser. No. 12/199,077 is a continuation-in-part of prior U.S. application Ser. No. 12/038,648, filed Feb. 27, 2008 and issued as U.S. Pat. No. 8,042,563 on Oct. 25, 2011, which is a continuation-in-part of prior U.S. application Ser. No. 11/871,803, filed Oct. 12, 2007 and issued as U.S. Pat. No. 7,967,022 on Jun. 28, 2011, which claims the benefit of U.S. Provisional Application Ser. No. 60/921,314, filed Apr. 2, 2007 and U.S. Provisional Application Ser. No. 60/904,024, filed Feb. 27, 2007. U.S. application Ser. No. 12/199,077 is a continuation-in-part of prior U.S. application Ser. No. 11/871,793, filed Oct. 12, 2007 and issued as U.S. Pat. No. 8,888,470 on Nov. 18, 2014, which claims the benefit of U.S. Provisional Application Ser. No. 60/921,314, filed Apr. 2, 2007 and U.S. Provisional Application Ser. No. 60/904,024, filed Feb. 27, 2007. U.S. application Ser. No. 12/199,077 is a continuation-in-part of prior U.S. application Ser. No. 11/871,787, filed Oct. 12, 2007 and published as U.S. Patent Application Publication No. 2008/0253911 on Oct. 16, 2008, now abandoned, which claims the benefit of U.S. Provisional Application Ser. No. 60/921,314, filed Apr. 2, 2007 and U.S. Provisional Application Ser. No. 60/904,024, filed Feb. 27, 2007. U.S. application Ser. No. 12/199,077 is a continuation-in-part of prior U.S. application Ser. No. 11/871,712, filed Oct. 12, 2007 and issued as U.S. Pat. No. 8,317,492 on Nov. 27, 2012, which claims the benefit of U.S. Provisional Application Ser. No. 60/921,314, filed Apr. 2, 2007 and U.S. Provisional Application Ser. No. 60/904,024, filed Feb. 27, 2007. U.S. application Ser. No. 12/199,077 is a continuation-in-part of prior U.S. application Ser. No. 11/871,680, filed Oct. 12, 2007 and issued as U.S. Pat. No. 8,273,049 on Sep. 25, 2012, which claims the benefit of U.S. Provisional Application Ser. No. 60/921,314, filed Apr. 2, 2007 and U.S. Provisional Application Ser. No. 60/904,024, filed Feb. 27, 2007.
| Number | Name | Date | Kind |
|---|---|---|---|
| 1693526 | Owens | Nov 1928 | A |
| 2529028 | Landon | Nov 1950 | A |
| 2741099 | Beane | Apr 1956 | A |
| 2816514 | Freese | Dec 1957 | A |
| 3016563 | De Jong | Jan 1962 | A |
| 3200648 | Waggaman | Aug 1965 | A |
| 3508656 | Serfass et al. | Apr 1970 | A |
| 3539081 | Norton et al. | Nov 1970 | A |
| 3656873 | Schiff | Apr 1972 | A |
| 3759483 | Baxter | Sep 1973 | A |
| RE27849 | Wortman | Dec 1973 | E |
| 3882861 | Kettering et al. | May 1975 | A |
| 3936729 | Winslow | Feb 1976 | A |
| 3996027 | Schnell et al. | Dec 1976 | A |
| 4096211 | Rameau | Jun 1978 | A |
| 4096859 | Agarwal et al. | Jun 1978 | A |
| 4133312 | Burd | Jan 1979 | A |
| 4155852 | Fischel et al. | May 1979 | A |
| 4161264 | Malmgren et al. | Jul 1979 | A |
| 4266814 | Gallagher | May 1981 | A |
| 4267040 | Schal et al. | May 1981 | A |
| 4282099 | Jones | Aug 1981 | A |
| 4299784 | Hense | Nov 1981 | A |
| 4309592 | Le Boeuf | Jan 1982 | A |
| 4322054 | Campbell | Mar 1982 | A |
| 4362156 | Feller et al. | Dec 1982 | A |
| 4369781 | Gilson et al. | Jan 1983 | A |
| 4398908 | Siposs | Aug 1983 | A |
| 4411783 | Dickens et al. | Oct 1983 | A |
| 4439188 | Dennehy et al. | Mar 1984 | A |
| 4441357 | Kahn et al. | Apr 1984 | A |
| 4479760 | Bilstad et al. | Oct 1984 | A |
| 4479761 | Bilstad et al. | Oct 1984 | A |
| 4479762 | Bilstad et al. | Oct 1984 | A |
| 4490254 | Gordon et al. | Dec 1984 | A |
| 4501405 | Usry | Feb 1985 | A |
| 4574876 | Aid | Mar 1986 | A |
| 4585442 | Mannes | Apr 1986 | A |
| 4623334 | Riddell | Nov 1986 | A |
| 4623450 | Vantard et al. | Nov 1986 | A |
| 4664891 | Cosentino et al. | May 1987 | A |
| 4680445 | Ogawa | Jul 1987 | A |
| 4695385 | Boag | Sep 1987 | A |
| 4718022 | Cochran | Jan 1988 | A |
| 4731072 | Aid | Mar 1988 | A |
| 4767526 | Vantard | Aug 1988 | A |
| 4770769 | Schael et al. | Sep 1988 | A |
| 4778451 | Kamen | Oct 1988 | A |
| 4779625 | Cole | Oct 1988 | A |
| 4784495 | Jonsson et al. | Nov 1988 | A |
| 4808161 | Kamen | Feb 1989 | A |
| 4822343 | Beiser | Apr 1989 | A |
| 4826482 | Kamen | May 1989 | A |
| 4828543 | Weiss et al. | May 1989 | A |
| 4833329 | Quint et al. | May 1989 | A |
| 4863461 | Jarvik | Sep 1989 | A |
| 4903655 | Vonderau et al. | Feb 1990 | A |
| 4906816 | van Leerdam | Mar 1990 | A |
| 4927411 | Pastrone et al. | May 1990 | A |
| 4950235 | Slate et al. | Aug 1990 | A |
| 4971700 | Tsuji et al. | Nov 1990 | A |
| 4976162 | Kamen | Dec 1990 | A |
| 4976729 | Holfert et al. | Dec 1990 | A |
| 4997570 | Polaschegg | Mar 1991 | A |
| 5024756 | Sternby | Jun 1991 | A |
| 5033513 | Bartholomew | Jul 1991 | A |
| 5061241 | Stephens, Jr. et al. | Oct 1991 | A |
| 5062774 | Kramer et al. | Nov 1991 | A |
| 5074838 | Kroyer | Dec 1991 | A |
| 5088515 | Kamen | Feb 1992 | A |
| 5088901 | Brauer | Feb 1992 | A |
| 5100554 | Polaschegg | Mar 1992 | A |
| 5105981 | Gehman | Apr 1992 | A |
| 5110447 | MacWilliams et al. | May 1992 | A |
| 5110477 | Howard et al. | May 1992 | A |
| 5116316 | Sertic et al. | May 1992 | A |
| 5125069 | O'Boyle | Jun 1992 | A |
| 5160325 | Nichols et al. | Nov 1992 | A |
| 5178182 | Kamen | Jan 1993 | A |
| 5245693 | Ford et al. | Sep 1993 | A |
| 5247434 | Peterson et al. | Sep 1993 | A |
| 5267956 | Beauchat | Dec 1993 | A |
| 5278072 | Wall et al. | Jan 1994 | A |
| 5300044 | Classey et al. | Apr 1994 | A |
| 5306242 | Joyce et al. | Apr 1994 | A |
| 5324422 | Colleran et al. | Jun 1994 | A |
| 5326476 | Grogan et al. | Jul 1994 | A |
| D350823 | Lanigan | Sep 1994 | S |
| D350850 | Angelini | Sep 1994 | S |
| 5349896 | Delaney, III et al. | Sep 1994 | A |
| 5350357 | Kamen et al. | Sep 1994 | A |
| 5351686 | Steuer et al. | Oct 1994 | A |
| 5362383 | Zimmerman et al. | Nov 1994 | A |
| 5378126 | Abrahamson et al. | Jan 1995 | A |
| 5381510 | Ford et al. | Jan 1995 | A |
| 5385540 | Abbott et al. | Jan 1995 | A |
| 5395316 | Martin | Mar 1995 | A |
| 5410255 | Bailey | Apr 1995 | A |
| 5411472 | Steg, Jr. et al. | May 1995 | A |
| 5413566 | Sevrain et al. | May 1995 | A |
| 5420962 | Bakke | May 1995 | A |
| 5421823 | Kamen et al. | Jun 1995 | A |
| 5423738 | Robinson et al. | Jun 1995 | A |
| 5429485 | Dodge | Jul 1995 | A |
| 5431626 | Bryant et al. | Jul 1995 | A |
| 5438510 | Bryant et al. | Aug 1995 | A |
| 5441231 | Payne et al. | Aug 1995 | A |
| 5441343 | Pylkki et al. | Aug 1995 | A |
| 5441636 | Chevallet et al. | Aug 1995 | A |
| 5472614 | Rossi | Dec 1995 | A |
| 5474683 | Bryant et al. | Dec 1995 | A |
| 5476368 | Rabenau et al. | Dec 1995 | A |
| 5476444 | Keeling et al. | Dec 1995 | A |
| 5482440 | Dennehey et al. | Jan 1996 | A |
| 5486286 | Peterson et al. | Jan 1996 | A |
| 5487827 | Peterson et al. | Jan 1996 | A |
| 5496273 | Pastrone et al. | Mar 1996 | A |
| 5516429 | Snodgrass et al. | May 1996 | A |
| 5527507 | Childers et al. | Jun 1996 | A |
| 5541344 | Becker et al. | Jul 1996 | A |
| 5542919 | Simon et al. | Aug 1996 | A |
| 5558255 | Sancoff et al. | Sep 1996 | A |
| 5568362 | Hansson | Oct 1996 | A |
| 5575310 | Kamen et al. | Nov 1996 | A |
| 5578012 | Kamen et al. | Nov 1996 | A |
| 5580460 | Polaschegg et al. | Dec 1996 | A |
| 5586438 | Fahy et al. | Dec 1996 | A |
| 5591344 | Kenley et al. | Jan 1997 | A |
| 5591389 | Esrock | Jan 1997 | A |
| 5593290 | Greisch et al. | Jan 1997 | A |
| 5628908 | Kamen et al. | May 1997 | A |
| 5632894 | White et al. | May 1997 | A |
| 5634896 | Bryant et al. | Jun 1997 | A |
| 5645531 | Thompson et al. | Jul 1997 | A |
| 5651765 | Haworth et al. | Jul 1997 | A |
| 5651893 | Kenley et al. | Jul 1997 | A |
| 5651898 | Imura | Jul 1997 | A |
| 5690831 | Kenley et al. | Nov 1997 | A |
| 5692729 | Harhen | Dec 1997 | A |
| 5702597 | Chevallet et al. | Dec 1997 | A |
| 5729653 | Magliochetti et al. | Mar 1998 | A |
| 5730720 | Sites et al. | Mar 1998 | A |
| 5744027 | Connell et al. | Apr 1998 | A |
| 5755275 | Rose et al. | May 1998 | A |
| 5755683 | Houle et al. | May 1998 | A |
| 5776091 | Brugger et al. | Jul 1998 | A |
| 5782508 | Bartholomew | Jul 1998 | A |
| 5797897 | Jepson et al. | Aug 1998 | A |
| 5875282 | Jordan et al. | Feb 1999 | A |
| 5879316 | Safar et al. | Mar 1999 | A |
| 5882047 | Ostrander et al. | Mar 1999 | A |
| 5899873 | Jones et al. | May 1999 | A |
| 5902476 | Twardowski et al. | May 1999 | A |
| 5931648 | Del Canizo | Aug 1999 | A |
| 5932103 | Kenley et al. | Aug 1999 | A |
| 5932110 | Shah et al. | Aug 1999 | A |
| 5938634 | Packard | Aug 1999 | A |
| 5947931 | Bierman et al. | Sep 1999 | A |
| 5989423 | Kamen et al. | Nov 1999 | A |
| 6039078 | Tamari | Mar 2000 | A |
| 6039877 | Chevallet et al. | Mar 2000 | A |
| 6041801 | Gray et al. | Mar 2000 | A |
| 6042784 | Wamsiedler et al. | Mar 2000 | A |
| 6044868 | Gretz et al. | Apr 2000 | A |
| 6047108 | Sword et al. | Apr 2000 | A |
| 6062068 | Bowling et al. | May 2000 | A |
| 6070761 | Bloom et al. | Jun 2000 | A |
| 6101406 | Hacker et al. | Aug 2000 | A |
| 6109881 | Snodgrass et al. | Aug 2000 | A |
| 6136201 | Shah et al. | Oct 2000 | A |
| 6139819 | Unger et al. | Oct 2000 | A |
| 6142164 | Wier et al. | Nov 2000 | A |
| 6142446 | Leinsing | Nov 2000 | A |
| 6146354 | Beil | Nov 2000 | A |
| 6146523 | Kenley et al. | Nov 2000 | A |
| 6146536 | Twardowski | Nov 2000 | A |
| 6153102 | Kenley et al. | Nov 2000 | A |
| 6159192 | Fowles et al. | Dec 2000 | A |
| 6171261 | Niermann et al. | Jan 2001 | B1 |
| 6176904 | Gupta | Jan 2001 | B1 |
| 6210361 | Kamen et al. | Apr 2001 | B1 |
| 6213996 | Jepson et al. | Apr 2001 | B1 |
| 6223130 | Gray et al. | Apr 2001 | B1 |
| 6234989 | Brierton et al. | May 2001 | B1 |
| 6234997 | Kamen et al. | May 2001 | B1 |
| RE37324 | Esrock | Aug 2001 | E |
| 6274303 | Wowk et al. | Aug 2001 | B1 |
| 6277272 | Nikaido et al. | Aug 2001 | B1 |
| 6277277 | Jacobi et al. | Aug 2001 | B1 |
| 6284131 | Hogard et al. | Sep 2001 | B1 |
| 6302653 | Bryant et al. | Oct 2001 | B1 |
| 6321597 | Demers et al. | Nov 2001 | B1 |
| 6327895 | Jeppsson et al. | Dec 2001 | B1 |
| 6331778 | Dailey et al. | Dec 2001 | B1 |
| 6336003 | Mitsunaga et al. | Jan 2002 | B1 |
| 6336911 | Westerbeck | Jan 2002 | B1 |
| 6347633 | Groth et al. | Feb 2002 | B1 |
| 6382923 | Gray | May 2002 | B1 |
| 6406426 | Reuss et al. | Jun 2002 | B1 |
| 6406452 | Westerbeck | Jun 2002 | B1 |
| 6413233 | Sites et al. | Jul 2002 | B1 |
| 6415797 | Groth et al. | Jul 2002 | B1 |
| 6416293 | Bouchard et al. | Jul 2002 | B1 |
| 6423053 | Lee | Jul 2002 | B1 |
| 6464666 | Augustine et al. | Oct 2002 | B1 |
| 6480257 | Cassidy et al. | Nov 2002 | B2 |
| 6485263 | Bryant et al. | Nov 2002 | B1 |
| 6491656 | Morris | Dec 2002 | B1 |
| 6497676 | Childers et al. | Dec 2002 | B1 |
| 6517510 | Stewart et al. | Feb 2003 | B1 |
| 6520747 | Gray et al. | Feb 2003 | B2 |
| 6527758 | Ko | Mar 2003 | B2 |
| 6529775 | Whitebook et al. | Mar 2003 | B2 |
| 6535689 | Augustine et al. | Mar 2003 | B2 |
| 6537445 | Muller | Mar 2003 | B2 |
| 6539172 | Akahane | Mar 2003 | B2 |
| 6543814 | Bartholomew | Apr 2003 | B2 |
| 6558340 | Traeger | May 2003 | B1 |
| 6579253 | Burbank et al. | Jun 2003 | B1 |
| 6579496 | Fausset et al. | Jun 2003 | B1 |
| RE38203 | Kelly | Jul 2003 | E |
| 6595944 | Balschat et al. | Jul 2003 | B2 |
| 6595948 | Suzuki et al. | Jul 2003 | B2 |
| 6604908 | Bryant et al. | Aug 2003 | B1 |
| 6608968 | Bakke | Aug 2003 | B2 |
| 6620119 | Utterberg et al. | Sep 2003 | B1 |
| 6649063 | Brugger et al. | Nov 2003 | B2 |
| 6660974 | Faries, Jr. et al. | Dec 2003 | B2 |
| 6663353 | Lipscomb et al. | Dec 2003 | B2 |
| 6663359 | Gray | Dec 2003 | B2 |
| 6673314 | Burbank et al. | Jan 2004 | B1 |
| 6709417 | Houle et al. | Mar 2004 | B1 |
| 6722865 | Domroese | Apr 2004 | B2 |
| 6723062 | Westberg et al. | Apr 2004 | B1 |
| 6726656 | Kamen et al. | Apr 2004 | B2 |
| 6743201 | Donig et al. | Jun 2004 | B1 |
| 6749403 | Bryant et al. | Jun 2004 | B2 |
| 6752172 | Lauer | Jun 2004 | B2 |
| 6758975 | Peabody et al. | Jul 2004 | B2 |
| 6768085 | Faries et al. | Jul 2004 | B2 |
| 6775473 | Augustine et al. | Aug 2004 | B2 |
| 6788885 | Mitsunaga et al. | Sep 2004 | B2 |
| 6808369 | Gray et al. | Oct 2004 | B2 |
| 6814547 | Childers et al. | Nov 2004 | B2 |
| 6814718 | McGuckin, Jr. et al. | Nov 2004 | B2 |
| 6818179 | Edgson et al. | Nov 2004 | B1 |
| 6826948 | Bhatti et al. | Dec 2004 | B1 |
| 6858019 | McGuckin, Jr. et al. | Feb 2005 | B2 |
| 6860866 | Graf et al. | Mar 2005 | B1 |
| 6868309 | Begelman | Mar 2005 | B1 |
| 6877713 | Gray et al. | Apr 2005 | B1 |
| 6905314 | Danby | Jun 2005 | B2 |
| 6905479 | Bouchard et al. | Jun 2005 | B1 |
| 6929751 | Bowman et al. | Aug 2005 | B2 |
| 6939471 | Gross et al. | Sep 2005 | B2 |
| 6949079 | Westberg et al. | Sep 2005 | B1 |
| 6953323 | Childers et al. | Oct 2005 | B2 |
| 7029245 | Maianti et al. | Apr 2006 | B2 |
| 7041076 | Westberg et al. | May 2006 | B1 |
| 7083719 | Bowman et al. | Aug 2006 | B2 |
| 7122210 | Elisabettini et al. | Oct 2006 | B2 |
| 7124996 | Clarke et al. | Oct 2006 | B2 |
| 7147613 | Burbank et al. | Dec 2006 | B2 |
| 7153286 | Busby et al. | Dec 2006 | B2 |
| 7168334 | Drott | Jan 2007 | B1 |
| 7169303 | Sullivan et al. | Jan 2007 | B2 |
| 7175397 | Claude et al. | Feb 2007 | B2 |
| 7175606 | Bowman et al. | Feb 2007 | B2 |
| 7214210 | Kamen et al. | May 2007 | B2 |
| 7232418 | Neri et al. | Jun 2007 | B2 |
| 7238164 | Childers et al. | Jul 2007 | B2 |
| 7273465 | Ash | Sep 2007 | B2 |
| 7284374 | Buerger et al. | Oct 2007 | B2 |
| 7300413 | Burbank et al. | Nov 2007 | B2 |
| 7303540 | O'Mahony et al. | Dec 2007 | B2 |
| 7318292 | Helbling et al. | Jan 2008 | B2 |
| 7318892 | Connell et al. | Jan 2008 | B2 |
| 7410294 | Shiraki et al. | Aug 2008 | B2 |
| 7461968 | Demers et al. | Dec 2008 | B2 |
| 7465285 | Hutchinson et al. | Dec 2008 | B2 |
| 7476209 | Gara et al. | Jan 2009 | B2 |
| 7488448 | Wieting et al. | Feb 2009 | B2 |
| 7500962 | Childers et al. | Mar 2009 | B2 |
| 7544179 | Distler et al. | Jun 2009 | B2 |
| 7559524 | Gray et al. | Jul 2009 | B2 |
| 7563240 | Gross et al. | Jul 2009 | B2 |
| 7563248 | Smisson, III et al. | Jul 2009 | B2 |
| 7601636 | Dumas et al. | Oct 2009 | B2 |
| 7632078 | Demers et al. | Dec 2009 | B2 |
| 7632080 | Tracey et al. | Dec 2009 | B2 |
| 7648627 | Beden et al. | Jan 2010 | B2 |
| 7662286 | Childers et al. | Feb 2010 | B2 |
| 7717682 | Orr | May 2010 | B2 |
| 7727176 | Tonelli et al. | Jun 2010 | B2 |
| 7744553 | Kelly et al. | Jun 2010 | B2 |
| 7776006 | Childers et al. | Aug 2010 | B2 |
| 7776301 | Comrie et al. | Aug 2010 | B2 |
| 7780619 | Brugger et al. | Aug 2010 | B2 |
| 7789849 | Busby et al. | Sep 2010 | B2 |
| 7794141 | Perry et al. | Sep 2010 | B2 |
| 7798997 | Kamen et al. | Sep 2010 | B2 |
| 7815595 | Busby et al. | Oct 2010 | B2 |
| 7867214 | Childers et al. | Jan 2011 | B2 |
| 7892197 | Folden et al. | Feb 2011 | B2 |
| 7896830 | Gura et al. | Mar 2011 | B2 |
| 7900659 | Whitley et al. | Mar 2011 | B2 |
| 7935074 | Plahey | May 2011 | B2 |
| 7935250 | Castellano et al. | May 2011 | B2 |
| 7967022 | Grant et al. | Jun 2011 | B2 |
| 8002726 | Karoor et al. | Aug 2011 | B2 |
| 8029454 | Kelly et al. | Oct 2011 | B2 |
| 8042563 | Grant et al. | Oct 2011 | B2 |
| 8066671 | Busby et al. | Nov 2011 | B2 |
| 8075526 | Busby et al. | Dec 2011 | B2 |
| 8137553 | Fulkerson et al. | Mar 2012 | B2 |
| 8246826 | Wilt et al. | Aug 2012 | B2 |
| 8266967 | Kitani et al. | Sep 2012 | B2 |
| 8273049 | Demers et al. | Sep 2012 | B2 |
| 8292594 | Tracey et al. | Oct 2012 | B2 |
| 8298152 | Konig et al. | Oct 2012 | B2 |
| 8317492 | Demers et al. | Nov 2012 | B2 |
| 8357298 | Demers et al. | Jan 2013 | B2 |
| 8366316 | Kamen et al. | Feb 2013 | B2 |
| 8393690 | Grant et al. | Mar 2013 | B2 |
| 8409441 | Wilt et al. | Apr 2013 | B2 |
| 8425471 | Grant et al. | Apr 2013 | B2 |
| 8444587 | Kelly et al. | May 2013 | B2 |
| 8459292 | Wilt et al. | Jun 2013 | B2 |
| 8491184 | Kamen et al. | Jul 2013 | B2 |
| 8499780 | Wilt et al. | Aug 2013 | B2 |
| 8512553 | Cicchello et al. | Aug 2013 | B2 |
| 8535525 | Heyes et al. | Sep 2013 | B2 |
| 8545698 | Wilt et al. | Oct 2013 | B2 |
| 8562834 | Kamen et al. | Oct 2013 | B2 |
| 8597505 | Fulkerson et al. | Dec 2013 | B2 |
| 8721879 | Van der Merwe et al. | May 2014 | B2 |
| 8721884 | Wilt et al. | May 2014 | B2 |
| 8771508 | Grant et al. | Jul 2014 | B2 |
| 8858787 | Muller et al. | Oct 2014 | B2 |
| 8863772 | Dale et al. | Oct 2014 | B2 |
| 8870549 | Tracey et al. | Oct 2014 | B2 |
| 8888470 | Demers et al. | Nov 2014 | B2 |
| 8926294 | Demers et al. | Jan 2015 | B2 |
| 8968232 | Kamen et al. | Mar 2015 | B2 |
| 8985133 | Grant et al. | Mar 2015 | B2 |
| 8992075 | Kamen et al. | Mar 2015 | B2 |
| 8992189 | Wilt et al. | Mar 2015 | B2 |
| 9028691 | Grant et al. | May 2015 | B2 |
| 9115708 | van der Merwe et al. | Aug 2015 | B2 |
| 9272082 | Demers et al. | Mar 2016 | B2 |
| 9302037 | Wilt et al. | Apr 2016 | B2 |
| 9364655 | Grant et al. | Jun 2016 | B2 |
| 9517295 | Wilt et al. | Dec 2016 | B2 |
| 9535021 | Kamen et al. | Jan 2017 | B2 |
| 9539379 | Grant et al. | Jan 2017 | B2 |
| 9550018 | Demers et al. | Jan 2017 | B2 |
| 9555179 | Wilt et al. | Jan 2017 | B2 |
| 9597442 | Wilt | Mar 2017 | B2 |
| 9603985 | Wilt et al. | Mar 2017 | B2 |
| 9649418 | Demers et al. | May 2017 | B2 |
| 9677554 | Wilt et al. | Jun 2017 | B2 |
| 9700660 | Demers et al. | Jul 2017 | B2 |
| 9700711 | Grant et al. | Jul 2017 | B2 |
| 9717834 | Wilt et al. | Aug 2017 | B2 |
| 9724458 | Grant et al. | Aug 2017 | B2 |
| 9795728 | Grant et al. | Oct 2017 | B2 |
| 9951768 | Grant et al. | Apr 2018 | B2 |
| 9987407 | Grant | Jun 2018 | B2 |
| 9999717 | Van Der Merwe et al. | Jun 2018 | B2 |
| 10060867 | Kamen et al. | Aug 2018 | B2 |
| 10077766 | Demers et al. | Sep 2018 | B2 |
| 10098998 | Wilt | Oct 2018 | B2 |
| 10201650 | Wilt et al. | Feb 2019 | B2 |
| 10302075 | Tracey et al. | May 2019 | B2 |
| 20020056672 | Lyle et al. | May 2002 | A1 |
| 20020092103 | Bruno et al. | Jul 2002 | A1 |
| 20020103453 | Burbank et al. | Aug 2002 | A1 |
| 20020150476 | Lucke et al. | Oct 2002 | A1 |
| 20020179505 | Rovatti et al. | Dec 2002 | A1 |
| 20020179595 | Nagele | Dec 2002 | A1 |
| 20020182090 | Gray | Dec 2002 | A1 |
| 20030100858 | Utterberg et al. | May 2003 | A1 |
| 20030114795 | Faries et al. | Jun 2003 | A1 |
| 20030194328 | Bryant et al. | Oct 2003 | A1 |
| 20030194332 | Jahn et al. | Oct 2003 | A1 |
| 20030195453 | Han et al. | Oct 2003 | A1 |
| 20030195454 | Wariar et al. | Oct 2003 | A1 |
| 20030220599 | Lundtveit et al. | Nov 2003 | A1 |
| 20030220605 | Bowman, Jr. et al. | Nov 2003 | A1 |
| 20030220607 | Busby et al. | Nov 2003 | A1 |
| 20030229302 | Robinson et al. | Dec 2003 | A1 |
| 20030230191 | Ohrle et al. | Dec 2003 | A1 |
| 20040001766 | Maianti et al. | Jan 2004 | A1 |
| 20040009096 | Wellman | Jan 2004 | A1 |
| 20040019313 | Childers et al. | Jan 2004 | A1 |
| 20040091374 | Gray | May 2004 | A1 |
| 20040101026 | Nitta et al. | May 2004 | A1 |
| 20040136843 | Jahn et al. | Jul 2004 | A1 |
| 20040138607 | Burbank et al. | Jul 2004 | A1 |
| 20040176724 | Kamen et al. | Sep 2004 | A1 |
| 20040211718 | Deguchi et al. | Oct 2004 | A1 |
| 20040245161 | Treu et al. | Dec 2004 | A1 |
| 20040262917 | Sunohara et al. | Dec 2004 | A1 |
| 20050020958 | Paolini et al. | Jan 2005 | A1 |
| 20050045540 | Connell et al. | Mar 2005 | A1 |
| 20050069425 | Gray et al. | Mar 2005 | A1 |
| 20050069427 | Roemuss et al. | Mar 2005 | A1 |
| 20050095141 | Lanigan et al. | May 2005 | A1 |
| 20050095154 | Tracey et al. | May 2005 | A1 |
| 20050126998 | Childers | Jun 2005 | A1 |
| 20050130332 | Ishii et al. | Jun 2005 | A1 |
| 20050131332 | Kelly et al. | Jun 2005 | A1 |
| 20050145010 | Vanderveen et al. | Jul 2005 | A1 |
| 20050209563 | Hopping et al. | Sep 2005 | A1 |
| 20050230292 | Beden et al. | Oct 2005 | A1 |
| 20050234385 | Vandlik | Oct 2005 | A1 |
| 20050242034 | Connell et al. | Nov 2005 | A1 |
| 20050274658 | Rosenbaum et al. | Dec 2005 | A1 |
| 20060002823 | Feldstein | Jan 2006 | A1 |
| 20060093531 | Tremoulet et al. | May 2006 | A1 |
| 20060184084 | Ware et al. | Aug 2006 | A1 |
| 20060195064 | Plahey et al. | Aug 2006 | A1 |
| 20060241550 | Kamen et al. | Oct 2006 | A1 |
| 20070060786 | Gura et al. | Mar 2007 | A1 |
| 20070077156 | Orr | Apr 2007 | A1 |
| 20070112297 | Plahey et al. | May 2007 | A1 |
| 20070135758 | Childers et al. | Jun 2007 | A1 |
| 20070166181 | Nilson | Jul 2007 | A1 |
| 20070253463 | Perry et al. | Nov 2007 | A1 |
| 20070255527 | Schick et al. | Nov 2007 | A1 |
| 20070278155 | Lo et al. | Dec 2007 | A1 |
| 20080015493 | Childers et al. | Jan 2008 | A1 |
| 20080015515 | Hopkins et al. | Jan 2008 | A1 |
| 20080021377 | Kienman et al. | Jan 2008 | A1 |
| 20080033346 | Childers et al. | Feb 2008 | A1 |
| 20080058697 | Kamen et al. | Mar 2008 | A1 |
| 20080058712 | Plahey | Mar 2008 | A1 |
| 20080077068 | Orr | Mar 2008 | A1 |
| 20080097283 | Plahey | Apr 2008 | A1 |
| 20080105600 | Connell et al. | May 2008 | A1 |
| 20080125693 | Gavin et al. | May 2008 | A1 |
| 20080132828 | Howard | Jun 2008 | A1 |
| 20080161751 | Plahey et al. | Jul 2008 | A1 |
| 20080175719 | Tracey et al. | Jul 2008 | A1 |
| 20080202591 | Grant et al. | Aug 2008 | A1 |
| 20080204086 | Park et al. | Aug 2008 | A1 |
| 20080205481 | Faries, Jr. et al. | Aug 2008 | A1 |
| 20080208103 | Demers et al. | Aug 2008 | A1 |
| 20080208111 | Kamen et al. | Aug 2008 | A1 |
| 20080215898 | Lu et al. | Sep 2008 | A1 |
| 20080216898 | Grant et al. | Sep 2008 | A1 |
| 20080240929 | Kamen et al. | Oct 2008 | A1 |
| 20080253427 | Kamen et al. | Oct 2008 | A1 |
| 20080253911 | Demers et al. | Oct 2008 | A1 |
| 20080253912 | Demers et al. | Oct 2008 | A1 |
| 20080287854 | Sun | Nov 2008 | A1 |
| 20090004033 | Demers et al. | Jan 2009 | A1 |
| 20090007642 | Busby et al. | Jan 2009 | A1 |
| 20090008331 | Wilt et al. | Jan 2009 | A1 |
| 20090009290 | Knelp et al. | Jan 2009 | A1 |
| 20090012447 | Huitt et al. | Jan 2009 | A1 |
| 20090012448 | Childers et al. | Jan 2009 | A1 |
| 20090012449 | Lee et al. | Jan 2009 | A1 |
| 20090012450 | Shah et al. | Jan 2009 | A1 |
| 20090012452 | Slepicka et al. | Jan 2009 | A1 |
| 20090012453 | Childers et al. | Jan 2009 | A1 |
| 20090012454 | Childers | Jan 2009 | A1 |
| 20090012455 | Childers et al. | Jan 2009 | A1 |
| 20090012456 | Childers et al. | Jan 2009 | A1 |
| 20090012457 | Childers et al. | Jan 2009 | A1 |
| 20090012458 | Childers et al. | Jan 2009 | A1 |
| 20090012460 | Steck et al. | Jan 2009 | A1 |
| 20090012461 | Childers et al. | Jan 2009 | A1 |
| 20090024070 | Gelfand et al. | Jan 2009 | A1 |
| 20090043239 | Gagel et al. | Feb 2009 | A1 |
| 20090076433 | Folden et al. | Mar 2009 | A1 |
| 20090076434 | Mischelevich et al. | Mar 2009 | A1 |
| 20090088675 | Kelly et al. | Apr 2009 | A1 |
| 20090088683 | Roger et al. | Apr 2009 | A1 |
| 20090095679 | Demers et al. | Apr 2009 | A1 |
| 20090101549 | Kamen | Apr 2009 | A1 |
| 20090101550 | Muller et al. | Apr 2009 | A1 |
| 20090101566 | Crnkovich et al. | Apr 2009 | A1 |
| 20090105621 | Boyd et al. | Apr 2009 | A1 |
| 20090107335 | Wilt | Apr 2009 | A1 |
| 20090107902 | Childers et al. | Apr 2009 | A1 |
| 20090112151 | Chapman et al. | Apr 2009 | A1 |
| 20090113335 | Sandoe et al. | Apr 2009 | A1 |
| 20090114582 | Grant et al. | May 2009 | A1 |
| 20090154524 | Girelli | Jun 2009 | A1 |
| 20090173682 | Robinson et al. | Jul 2009 | A1 |
| 20090182263 | Burbank et al. | Jul 2009 | A1 |
| 20090192367 | Braig et al. | Jul 2009 | A1 |
| 20090202367 | Gray et al. | Aug 2009 | A1 |
| 20100051529 | Grant et al. | Mar 2010 | A1 |
| 20100051551 | Grant et al. | Mar 2010 | A1 |
| 20100056975 | Dale et al. | Mar 2010 | A1 |
| 20100057016 | Dale et al. | Mar 2010 | A1 |
| 20100087777 | Hopping et al. | Apr 2010 | A1 |
| 20100133153 | Beden et al. | Jun 2010 | A1 |
| 20100137782 | Jansson et al. | Jun 2010 | A1 |
| 20100185134 | Houwen et al. | Jul 2010 | A1 |
| 20100187176 | Del Canizo Lopez et al. | Jul 2010 | A1 |
| 20100192686 | Kamen et al. | Aug 2010 | A1 |
| 20100296953 | Gray | Nov 2010 | A1 |
| 20100327849 | Kamen et al. | Dec 2010 | A1 |
| 20110005992 | Kelly et al. | Jan 2011 | A1 |
| 20110009797 | Kelly et al. | Jan 2011 | A1 |
| 20110092875 | Beck et al. | Apr 2011 | A1 |
| 20110105877 | Wilt et al. | May 2011 | A1 |
| 20110144569 | Britton et al. | Jun 2011 | A1 |
| 20110218600 | Kamen et al. | Sep 2011 | A1 |
| 20110299358 | Wilt et al. | Dec 2011 | A1 |
| 20110303588 | Kelly et al. | Dec 2011 | A1 |
| 20110303598 | Lo et al. | Dec 2011 | A1 |
| 20120035533 | Britton et al. | Feb 2012 | A1 |
| 20120071816 | Busby et al. | Mar 2012 | A1 |
| 20120106289 | Wilt et al. | May 2012 | A1 |
| 20120207627 | Demers et al. | Aug 2012 | A1 |
| 20130010825 | Kamen et al. | Jan 2013 | A1 |
| 20130020237 | Wilt et al. | Jan 2013 | A1 |
| 20130022483 | Wilt et al. | Jan 2013 | A1 |
| 20130032536 | Wilt et al. | Feb 2013 | A1 |
| 20130037480 | Wilt et al. | Feb 2013 | A1 |
| 20130037485 | Wilt et al. | Feb 2013 | A1 |
| 20130074959 | Demers et al. | Mar 2013 | A1 |
| 20130115105 | Tracey et al. | May 2013 | A1 |
| 20130126413 | Van der Merwe et al. | May 2013 | A1 |
| 20130177457 | Demers et al. | Jul 2013 | A1 |
| 20130284648 | Grant et al. | Oct 2013 | A1 |
| 20130304020 | Wilt et al. | Nov 2013 | A1 |
| 20130317454 | Grant et al. | Nov 2013 | A1 |
| 20140102299 | Wilt et al. | Apr 2014 | A1 |
| 20140102958 | Kamen et al. | Apr 2014 | A1 |
| 20140102970 | Wilt et al. | Apr 2014 | A1 |
| 20140112828 | Grant et al. | Apr 2014 | A1 |
| 20140153356 | Grant et al. | Jun 2014 | A1 |
| 20140199193 | Wilt et al. | Jul 2014 | A1 |
| 20140299544 | Wilt et al. | Oct 2014 | A1 |
| 20140309611 | Wilt et al. | Oct 2014 | A1 |
| 20140319041 | Wilt et al. | Oct 2014 | A1 |
| 20140322053 | van der Merwe et al. | Oct 2014 | A1 |
| 20150042366 | Wilt et al. | Feb 2015 | A1 |
| 20150050166 | Tracey et al. | Feb 2015 | A1 |
| 20150125319 | Demers et al. | May 2015 | A1 |
| 20150196698 | Grant et al. | Jul 2015 | A1 |
| 20150196699 | Wilt et al. | Jul 2015 | A9 |
| 20150204807 | Kamen et al. | Jul 2015 | A1 |
| 20150265760 | Wilt et al. | Sep 2015 | A1 |
| 20160030657 | Kelly et al. | Feb 2016 | A1 |
| 20160030658 | van der Merwe et al. | Feb 2016 | A1 |
| 20160058933 | Ballantyne et al. | Mar 2016 | A1 |
| 20160175505 | Demers et al. | Jun 2016 | A1 |
| 20160175506 | Wilt et al. | Jun 2016 | A1 |
| 20170000938 | Wilt et al. | Jan 2017 | A1 |
| 20170100533 | Wilt et al. | Apr 2017 | A1 |
| 20170112989 | Grant et al. | Apr 2017 | A1 |
| 20170130705 | Demers et al. | May 2017 | A1 |
| 20170143886 | Wilt et al. | May 2017 | A1 |
| 20170241926 | Kamen et al. | Aug 2017 | A1 |
| 20170252503 | Wilt | Sep 2017 | A1 |
| 20170296803 | Grant et al. | Oct 2017 | A1 |
| 20170319765 | Wilt et al. | Nov 2017 | A1 |
| 20170326282 | Wilt et al. | Nov 2017 | A1 |
| 20170342972 | Wilt et al. | Nov 2017 | A1 |
| 20170368252 | Grant et al. | Dec 2017 | A1 |
| 20180055984 | Grant et al. | Mar 2018 | A1 |
| 20180296746 | Van der Merwe et al. | Oct 2018 | A1 |
| 20180372084 | Grant et al. | Dec 2018 | A1 |
| 20190186483 | Demers et al. | Jan 2019 | A1 |
| 20190094163 | Kamen et al. | Mar 2019 | A1 |
| 20190160220 | Wilt et al. | May 2019 | A1 |
| Number | Date | Country |
|---|---|---|
| 2374187 | Apr 2000 | CN |
| 1830494 | Sep 2006 | CN |
| 3 328 744 | Feb 1985 | DE |
| 0 288 145 | Oct 1988 | EP |
| 0 687 474 | Dec 1995 | EP |
| 0 815 882 | Jan 1998 | EP |
| 0 829 266 | Mar 1998 | EP |
| 0 992 255 | Apr 2000 | EP |
| 1195171 | Apr 2002 | EP |
| 2 319 551 | May 2011 | EP |
| S60-077782 | May 1985 | JP |
| 63-106445 | Jul 1988 | JP |
| H09-099060 | Apr 1997 | JP |
| H11-210633 | Aug 1999 | JP |
| 2002-539896 | Nov 2002 | JP |
| 2003-509131 | Mar 2003 | JP |
| 2005-526574 | Sep 2005 | JP |
| 2006-204343 | Aug 2006 | JP |
| 2006-218130 | Aug 2006 | JP |
| 2006-522626 | Oct 2006 | JP |
| 2007-215557 | Aug 2007 | JP |
| 2008-006292 | Jan 2008 | JP |
| 2008-136673 | Jun 2008 | JP |
| 10-2002-0010601 | Feb 2002 | KR |
| 9411093 | May 1994 | WO |
| 9420158 | Sep 1994 | WO |
| 9640320 | Dec 1996 | WO |
| 98037801 | Sep 1998 | WO |
| 9839058 | Sep 1998 | WO |
| 9902206 | Jan 1999 | WO |
| 9910028 | Mar 1999 | WO |
| 0119430 | Mar 2001 | WO |
| 0137895 | May 2001 | WO |
| 0203879 | Jan 2002 | WO |
| 0230267 | Apr 2002 | WO |
| 03099353 | Dec 2003 | WO |
| 03099354 | Dec 2003 | WO |
| 2004041081 | May 2004 | WO |
| 2004060449 | Jul 2004 | WO |
| 2005044339 | May 2005 | WO |
| 2005044435 | May 2005 | WO |
| 2005089832 | Sep 2005 | WO |
| 2006088419 | Aug 2006 | WO |
| 2006120415 | Nov 2006 | WO |
| WO 2006120415 | Nov 2006 | WO |
| 2007120812 | Oct 2007 | WO |
| 2007126360 | Nov 2007 | WO |
| 2007149637 | Dec 2007 | WO |
| 2008028653 | Mar 2008 | WO |
| 2008053259 | May 2008 | WO |
| 2008106191 | Sep 2008 | WO |
| 2008106440 | Sep 2008 | WO |
| 2008106452 | Sep 2008 | WO |
| 2008106538 | Sep 2008 | WO |
| 2008118600 | Oct 2008 | WO |
| 2009051669 | Apr 2009 | WO |
| 2009094179 | Jul 2009 | WO |
| 2009094183 | Jul 2009 | WO |
| 2009094184 | Jul 2009 | WO |
| 2009094185 | Jul 2009 | WO |
| 2010027435 | Mar 2010 | WO |
| 2010027437 | Mar 2010 | WO |
| 2011053810 | May 2011 | WO |
| 2012006425 | Jan 2012 | WO |
| 2012162515 | Nov 2012 | WO |
| Entry |
|---|
| Bengtsson et al., Haemo dialysis software architecture design experiences. Proceedings of the 1999 International Conference on Software Engineering. ACM New York, NY. 1999:516-525. |
| Choppy et al., Architectural patterns for problem frames. IEE Proceedings: Software. 2005 Aug;152(4):190-208. |
| Gentilini et al., Multitasked closed-loop control in anesthesia. IEEE Eng Med Biol Mag. 2001 Jan-Feb;20(1):39-53. |
| Harel, Statecharts: A visual formalism for complex systems. Science of Computer Programming. 1987;8:231-274. |
| Krasner et al., A cookbook for using the model-view-controller user interface paradigm in smalltalk-80. JOOP. 1988 Aug;1(3):26-49. |
| Office Action for JP Application No. 2009-551724 filed Feb. 27, 2008, which Office Action is dated Nov. 28, 2012, and claims as pending for JP Application No. 2009-551724 as of Nov. 28, 2012. |
| Written Opinion for Application No. PCT/US2008/002636 dated Jul. 2, 2008. |
| International Preliminary Report on Patentability for Application No. PCT/US2008/002636 dated Sep. 11, 2009. |
| International Search Report and Written Opinion for Application No. PCT/US2008/055000 dated Aug. 1, 2008. |
| International Preliminary Report on Patentability for Application No. PCT/US2008/055000 dated Sep. 11, 2009. |
| International Search Report and Written Opinion for Application No. PCT/US2008/055168 dated Nov. 10, 2008. |
| International Preliminary Report on Patentability for Application No. PCT/US2008/055168 dated Sep. 11, 2009. |
| Invitation to Pay Additional Fees for Application No. PCT/US2008/055168 dated Aug. 5, 2008. |
| International Search Report and Written Opinion for Application No. PCT/US2008/055136 dated Jul. 24, 2008. |
| International Preliminary Report on Patentability for Application No. PCT/US2008/055136 dated Sep. 11, 2009. |
| Invitation to Pay Additional Fees for Application No. PCT/US2009/004866 dated Nov. 27, 2009. |
| International Search Report and Written Opinion for Application No. PCT/US2009/004866 dated Jan. 27, 2010. |
| International Preliminary Report on Patentability for Application No. PCT/US2009/004866 dated Mar. 10, 2011. |
| Invitation to Pay Additional Fees for Application No. PCT/US2009/004877 dated Dec. 8, 2009. |
| International Search Report and Written Opinion for Application No. PCT/US2009/004877 dated Feb. 12, 2010. |
| International Preliminary Report on Patentability for Application No. PCT/US2009/004877 dated Mar. 10, 2011. |
| Extended European Search Report for EP Application No. 13150786.5 filed Apr. 13, 2007, which Search Report is dated Mar. 28, 2013, and claims as pending for EP Application No. 13150786.5 as of Mar. 28, 2013. |
| Office Action for JP Application No. 2009-505495 filed Apr. 13, 2007, unpublished as of Aug. 3, 2012, which Office Action is dated May 8, 2012, and claims as pending for JP Application No. 2009-505495 as of May 8, 2012. |
| Written Opinion for Application No. PCT/US2007/009107 dated Aug. 17, 2007. |
| International Preliminary Report on Patentability for Application No. PCT/US2007/009107 dated Oct. 23, 2008. |
| Office Action for AU Application No. 2008312005 filed Oct. 10, 2008, which Office Action is dated Jan. 9, 2013, and claims as pending for AU Application No. 2008312005 as of Jan. 9, 2013. |
| Office Action for CA Application No. 2702385 filed Apr. 12, 2010, which Office Action is dated Nov. 20, 2014, and claims as pending for CA Application No. 2702385 as of Nov. 20, 2014. |
| Office Action for CN Application No. 20880121285.7 filed Oct. 10, 2008, published as CN 101986776, which Office Action is dated Oct. 10, 2012, and claims as pending for CN Application No. 20880121285.7 as of Oct. 10, 2012. |
| Office Action for CN Application No. 20880121285.7 filed Oct. 10, 2008, published as CN 101986776, which Office Action is dated Aug. 14, 2013, and claims as pending for CN Application No. 20880121285.7 as of Aug. 14, 2013. |
| Office Action for CN Application No. 20880121285.7 filed Oct. 10, 2008, published as CN 101986776, which Office Action is dated May 14, 2014, and claims as pending for CN Application No. 20880121285.7 as of May 14, 2014. |
| Examination Report for EP Application No. 08838971.3 filed Oct. 10, 2008, published as EP 2197513 on Jun. 23, 2010, which Examination Report is dated Jun. 21, 2013, and claims as pending for EP Application No. 08838971.3 as of Jun. 21, 2013. |
| Partial European Search Report for EP Application No. 11150584.8 filed Oct. 10, 2008, published as EP 2319551 on May 11, 2011, which Search Report is dated Mar. 30, 2011, and claims as pending for EP Application No. 11150584.8 as of Mar. 30, 2011. |
| Extended European Search Report for EP Application No. 11150584.8 filed Oct. 10, 2008, published as EP 2319551 on May 11, 2011, which Search Report is dated Jul. 26, 2011, and claims as pending for EP Application No. 11150584.8 as of Jul. 26, 2011. |
| Examination Report for EP Application No. 11150584.8 filed Oct. 10, 2008, published as EP 2319551 on May 11, 2011, which Examination Report is dated Oct. 16, 2012, and claims as pending for EP Application No. 11150584.8 as of Oct. 16, 2012. |
| Office Action for IN Application No. 3364/DELNP/2010 filed May 12, 2010, which Office Action is dated Oct. 17, 2017, and claims as pending for IN Application No. 3364/DELNP/2010 as of Oct. 17, 2017. |
| Office Action for JP Application No. 2010-528896 filed Oct. 10, 2008, which Office Action is dated Feb. 26, 2013, and claims as pending for JP Application No. 2010-528896 as of Feb. 26, 2013. |
| Office Action for KR Application No. Oct. 2010-7010384 filed May 11, 2010, which Office Action is dated Oct. 30, 2014, and claims as pending for KR Application No. 10-2010- 7010384 as of Oct. 30, 2014. |
| International Search Report and Written Opinion for Application No. PCT/US2008/011663 dated Feb. 20, 2009. |
| International Preliminary Report on Patentability for Application No. PCT/US2008/011663 dated Apr. 22, 2010. |
| Invitation to Pay Additional Fees for Application No. PCT/US2009/000433 dated Jun. 4, 2009. |
| International Search Report and Written Opinion for Application No. PCT/US2009/000433 dated Sep. 25, 2009. |
| International Preliminary Report on Patentability for Application No. PCT/US2009/000433 dated Aug. 5, 2010. |
| International Search Report and Written Opinion for Application No. PCT/US2008/055021 dated Jul. 23, 2008. |
| International Preliminary Report on Patentability for Application No. PCT/US2008/055021 dated Sep. 11, 2009. |
| International Search Report and Written Opinion for International Application No. PCT/US2010/054772 dated May 9, 2011. |
| International Preliminary Report on Patentability for International Application No. PCT/US2010/054772 dated May 1, 2012. |
| Invitation to Pay Additional Fees for PCT Application No. PCT/US2012/039369 dated Sep. 27, 2012. |
| International Search Report and Written Opinion for PCT Application No. PCT/US2012/039369 dated Jan. 16, 2013. |
| Office Action for U.S. Appl. No. 12/072,908 filed Feb. 27, 2008, published as US 2009-0008331 on Jan. 8, 2009 which Office Action is dated Oct. 15, 2010, and claims as pending for U.S. Appl. No. 12/072,908 filed Oct. 15, 2010. |
| Office Action for U.S. Appl. No. 12/072,908 filed Feb. 27, 2008, published as US 2009-0008331 on Jan. 8, 2009 which Office Action is dated Jul. 15, 2011, and claims as pending for U.S. Appl. No. 12/072,908 filed Jul. 15, 2011. |
| Office Action for U.S. Appl. No. 11/871,680 filed Oct. 12, 2007, published as US 20080208103 on Aug. 28, 2008 which Office Action is dated Aug. 22, 2011, and claims as pending for U.S. Appl. No. 11/871,680 filed Aug. 22, 2011. |
| Office Action for U.S. Appl. No. 11/871,712 filed Oct. 12, 2007, published as US 2009/0004033 on Jan. 1, 2009, which Office Action is dated Feb. 4, 2010, and claims as pending for U.S. Appl. No. 11/871,712 filed Feb. 4, 2010. |
| Office Action for U.S. Appl. No. 11/871,712 filed Oct. 12, 2007, published as US 20090004033 on Jan. 1, 2009, which Office Action is dated Oct. 15, 2010, and claims as pending for U.S. Appl. No. 11/871,712 filed Oct. 15, 2010. |
| Office Action for U.S. Appl. No. 11/871,712 filed Oct. 12, 2007, published as US 20090004033 on Jan. 1, 2009, which Office Action is dated Feb. 7, 2011, and claims as pending for U.S. Appl. No. 11/871,712 filed Feb. 7, 2011. |
| Office Action for U.S. Appl. No. 11/871,787 filed Oct. 12, 2007, published as US 20080253911 on Oct. 16, 2008, which Office Action is dated Apr. 14, 2011, and claims as pending for U.S. Appl. No. 11/871,787 filed Apr. 14, 2011. |
| Office Action for U.S. Appl. No. 11/871,793 filed Oct. 12, 2007, published as US 20080253912 on Oct. 16, 2008, which Office Action is dated Apr. 28, 2011, and claims as pending for U.S. Appl. No. 11/871,793 filed Apr. 28, 2011. |
| Office Action for U.S. Appl. No. 11/871,793 filed Oct. 12, 2007, published as US 20080253912 on Oct. 16, 2008, which Office Action is dated Nov. 28, 2011, and claims as pending for U.S. Appl. No. 11/871,793 filed Nov. 28, 2011. |
| Office Action for U.S. Appl. No. 11/871,793 filed Oct. 12, 2007, published as US 20080253912 on Oct. 16, 2008, which Office Action is dated Oct. 29, 2013, and claims as pending for U.S. Appl. No. 11/871,793 filed Oct. 29, 2013. |
| Office Action for U.S. Appl. No. 12/038,648 filed Feb. 27, 2008, published as US 2008-0216898 on Sep. 11, 2008, which Office Action is dated Oct. 1, 2010, and claims as pending for U.S. Appl. No. 12/038,648 filed Oct. 1, 2010. |
| Office Action for U.S. Appl. No. 12/038,474 filed Feb. 27, 2008, published as US 2008-0253427 on Oct. 16, 2008, which Office Action is dated Feb. 7, 2011, and claims as pending for U.S. Appl. No. 12/038,474 filed Feb. 7, 2011. |
| Office Action for U.S. Appl. No. 12/038,474 filed Feb. 27, 2008, published as US 2008-0253427 on Oct. 16, 2008, which Office Action is dated Sep. 1, 2011, and claims as pending for U.S. Appl. No. 12/038,474 as of Sep. 1, 2011. |
| Office Action for U.S. Appl. No. 12/038,474 filed Feb. 27, 2008, published as US 2008-0253427 on Oct. 16, 2008, which Office Action is dated May 15, 2012, and claims as pending for U.S. Appl. No. 12/038,474 filed May 15, 2012. |
| Office Action for U.S. Appl. No. 12/199,176 filed Aug. 27, 2008, published as 20100056975 on Mar. 4, 2010, which Office Action is dated Nov. 22, 2010, and claims as pending for U.S. Appl. No. 12/199,176 filed Nov. 22, 2010. |
| Office Action for U.S. Appl. No. 12/199,176 filed Aug. 27, 2008, published as 2010-0056975 on Mar. 4, 2010, which Office Action is dated Sep. 2, 2011, and claims as pending for U.S. Appl. No. 12/199,176 as of Sep. 2, 2011. |
| Office Action for U.S. Appl. No. 12/199,176 filed Aug. 27, 2008, published as 20100056975 on Mar. 4, 2010, which Office Action is dated Feb. 10, 2012, and claims as pending for U.S. Appl. No. 12/199,176 filed Feb. 10, 2012. |
| Office Action for U.S. Appl. No. 11/787,212 filed Apr. 13, 2007, published as 20080175719 on Jul. 24, 2008, which Office Action is dated May 26, 2010, and claims as pending for U.S. Appl. No. 11/787,212 filed May 26, 2010. |
| Office Action for U.S. Appl. No. 11/787,212 filed Apr. 13, 2007, published as 20080175719 on Jul. 24, 2008, which Office Action is dated Feb. 7, 2011, and claims as pending for U.S. Appl. No. 11/787,212 filed Feb. 7, 2011. |
| Office Action for U.S. Appl. No. 11/787,213 filed Apr. 13, 2007, published as 20080058697 on Mar. 6, 2008, which Office Action is dated Mar. 18, 2010, and claims as pending for U.S. Appl. No. 11/787,213 filed Mar. 18, 2010. |
| Office Action for U.S. Appl. No. 11/787,112 filed Apr. 13, 2007, published as US 2007/0253463 on Nov. 1, 2007, which Office Action is dated Nov. 21, 2008, and claims as pending for U.S. Appl. No. 11/787,112 filed Nov. 21, 2008. |
| Office Action for U.S. Appl. No. 11/871,821 filed Oct. 12, 2007, published as US 20080240929 on Oct. 2, 2008, which Office Action is dated Sep. 23, 2009, and claims as pending for U.S. Appl. No. 11/871,821 filed Sep. 23, 2009. |
| Office Action for U.S. Appl. No. 11/871,828 filed Oct. 12, 2007, published as US 20080208111 on Aug. 28, 2008, which Office Action is dated Mar. 11, 2010, and claims as pending for U.S. Appl. No. 11/871,828 filed Mar. 11, 2010. |
| Office Action for U.S. Appl. No. 11/871,828 filed Oct. 12, 2007, published as US 20080208111 on Aug. 28, 2008, which Office Action is dated Nov. 26, 2010, and claims as pending for U.S. Appl. No. 11/871,828 filed Nov. 26, 2010. |
| Number | Date | Country | |
|---|---|---|---|
| 20180339094 A1 | Nov 2018 | US |
| Number | Date | Country | |
|---|---|---|---|
| 60903582 | Feb 2007 | US | |
| 60904024 | Feb 2007 | US | |
| 60921314 | Apr 2007 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 14692801 | Apr 2015 | US |
| Child | 15996247 | US | |
| Parent | 12199077 | Aug 2008 | US |
| Child | 14692801 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 12072908 | Feb 2008 | US |
| Child | 12199077 | US | |
| Parent | 12038648 | Feb 2008 | US |
| Child | 12072908 | US | |
| Parent | 11871803 | Oct 2007 | US |
| Child | 12038648 | US | |
| Parent | 12038474 | Feb 2008 | US |
| Child | 12199077 | US | |
| Parent | 11871821 | Oct 2007 | US |
| Child | 12038474 | US | |
| Parent | 11871680 | Oct 2007 | US |
| Child | 12199077 | US | |
| Parent | 11871712 | Oct 2007 | US |
| Child | 11871680 | US | |
| Parent | 11871787 | Oct 2007 | US |
| Child | 11871712 | US | |
| Parent | 11871793 | Oct 2007 | US |
| Child | 11871787 | US |
